WO2024013736A1 - Process for preparing substituted benzamides - Google Patents
Process for preparing substituted benzamides Download PDFInfo
- Publication number
- WO2024013736A1 WO2024013736A1 PCT/IL2023/050715 IL2023050715W WO2024013736A1 WO 2024013736 A1 WO2024013736 A1 WO 2024013736A1 IL 2023050715 W IL2023050715 W IL 2023050715W WO 2024013736 A1 WO2024013736 A1 WO 2024013736A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- halogen
- compound
- acid
- formula
- alkyl
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 3
- 229940054066 benzamide antipsychotics Drugs 0.000 title description 2
- 150000003936 benzamides Chemical class 0.000 title description 2
- 150000003839 salts Chemical class 0.000 claims abstract description 36
- 150000001875 compounds Chemical class 0.000 claims description 219
- 229910052736 halogen Inorganic materials 0.000 claims description 187
- 150000002367 halogens Chemical group 0.000 claims description 187
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical class CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 120
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 108
- 239000000203 mixture Substances 0.000 claims description 95
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 78
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims description 78
- 238000000034 method Methods 0.000 claims description 78
- 238000006243 chemical reaction Methods 0.000 claims description 66
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 54
- 125000004104 aryloxy group Chemical group 0.000 claims description 49
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims description 49
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims description 48
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 48
- 125000005248 alkyl aryloxy group Chemical group 0.000 claims description 48
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 45
- 239000003960 organic solvent Substances 0.000 claims description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 41
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical class CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 40
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical class CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 36
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical class ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 36
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical class CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 36
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical class CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 36
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical class OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 36
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 36
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 33
- -1 acyclic hydrocarbons Chemical class 0.000 claims description 33
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 30
- 239000002253 acid Substances 0.000 claims description 29
- 239000002585 base Substances 0.000 claims description 29
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical class C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 28
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical class ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 24
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 24
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 21
- 239000003444 phase transfer catalyst Substances 0.000 claims description 21
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 19
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical class CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 18
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical class C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 18
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 18
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 18
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 18
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 18
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 claims description 16
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 16
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 16
- 238000010438 heat treatment Methods 0.000 claims description 16
- 235000011054 acetic acid Nutrition 0.000 claims description 15
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 15
- 235000011181 potassium carbonates Nutrition 0.000 claims description 15
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 claims description 15
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical class CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 14
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims description 14
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 claims description 14
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Chemical class C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 14
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 13
- 229960000583 acetic acid Drugs 0.000 claims description 13
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical class C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 12
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims description 12
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 12
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical class CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 12
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 claims description 11
- 235000011121 sodium hydroxide Nutrition 0.000 claims description 11
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 claims description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- 229930195733 hydrocarbon Natural products 0.000 claims description 10
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Chemical class CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 claims description 10
- 229940011051 isopropyl acetate Drugs 0.000 claims description 10
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical class CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 claims description 10
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 150000003983 crown ethers Chemical class 0.000 claims description 9
- 229910052751 metal Inorganic materials 0.000 claims description 9
- 239000002184 metal Substances 0.000 claims description 9
- 150000002826 nitrites Chemical class 0.000 claims description 9
- 239000011736 potassium bicarbonate Substances 0.000 claims description 9
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 9
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 9
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 9
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 claims description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 8
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 8
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 claims description 8
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 8
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 8
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical class COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 claims description 8
- HTZCNXWZYVXIMZ-UHFFFAOYSA-M benzyl(triethyl)azanium;chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC1=CC=CC=C1 HTZCNXWZYVXIMZ-UHFFFAOYSA-M 0.000 claims description 8
- 239000003054 catalyst Substances 0.000 claims description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 8
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 8
- 235000017550 sodium carbonate Nutrition 0.000 claims description 8
- NHGXDBSUJJNIRV-UHFFFAOYSA-M tetrabutylammonium chloride Chemical compound [Cl-].CCCC[N+](CCCC)(CCCC)CCCC NHGXDBSUJJNIRV-UHFFFAOYSA-M 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- 239000001257 hydrogen Substances 0.000 claims description 7
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical class CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 7
- 235000010288 sodium nitrite Nutrition 0.000 claims description 7
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical class ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 6
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical class C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 6
- 150000001298 alcohols Chemical class 0.000 claims description 6
- 125000001931 aliphatic group Chemical class 0.000 claims description 6
- 125000003118 aryl group Chemical class 0.000 claims description 6
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical class ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 claims description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 6
- 150000002170 ethers Chemical class 0.000 claims description 6
- 150000002576 ketones Chemical class 0.000 claims description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 6
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 claims description 6
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 claims description 6
- 150000002825 nitriles Chemical class 0.000 claims description 6
- 229920000570 polyether Polymers 0.000 claims description 6
- 229920001223 polyethylene glycol Polymers 0.000 claims description 6
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 claims description 6
- 235000011118 potassium hydroxide Nutrition 0.000 claims description 6
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 claims description 6
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 5
- 150000004703 alkoxides Chemical class 0.000 claims description 5
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 5
- 229910001507 metal halide Inorganic materials 0.000 claims description 5
- 150000005309 metal halides Chemical class 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 claims description 5
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 4
- QSNSCYSYFYORTR-UHFFFAOYSA-N 4-chloroaniline Chemical compound NC1=CC=C(Cl)C=C1 QSNSCYSYFYORTR-UHFFFAOYSA-N 0.000 claims description 4
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 4
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 4
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 4
- 235000019253 formic acid Nutrition 0.000 claims description 4
- 229940083124 ganglion-blocking antiadrenergic secondary and tertiary amines Drugs 0.000 claims description 4
- 229940098779 methanesulfonic acid Drugs 0.000 claims description 4
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Chemical class CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 claims description 4
- XKBGEWXEAPTVCK-UHFFFAOYSA-M methyltrioctylammonium chloride Chemical compound [Cl-].CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC XKBGEWXEAPTVCK-UHFFFAOYSA-M 0.000 claims description 4
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 claims description 4
- 150000004714 phosphonium salts Chemical class 0.000 claims description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 4
- 229910052700 potassium Inorganic materials 0.000 claims description 4
- 239000011591 potassium Substances 0.000 claims description 4
- 239000001103 potassium chloride Substances 0.000 claims description 4
- 235000011164 potassium chloride Nutrition 0.000 claims description 4
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 claims description 4
- 229910000105 potassium hydride Inorganic materials 0.000 claims description 4
- 150000003141 primary amines Chemical class 0.000 claims description 4
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 239000012312 sodium hydride Substances 0.000 claims description 4
- 229910000104 sodium hydride Inorganic materials 0.000 claims description 4
- IPILPUZVTYHGIL-UHFFFAOYSA-M tributyl(methyl)azanium;chloride Chemical compound [Cl-].CCCC[N+](C)(CCCC)CCCC IPILPUZVTYHGIL-UHFFFAOYSA-M 0.000 claims description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 3
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 claims description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 3
- AZFNGPAYDKGCRB-XCPIVNJJSA-M [(1s,2s)-2-amino-1,2-diphenylethyl]-(4-methylphenyl)sulfonylazanide;chlororuthenium(1+);1-methyl-4-propan-2-ylbenzene Chemical compound [Ru+]Cl.CC(C)C1=CC=C(C)C=C1.C1=CC(C)=CC=C1S(=O)(=O)[N-][C@@H](C=1C=CC=CC=1)[C@@H](N)C1=CC=CC=C1 AZFNGPAYDKGCRB-XCPIVNJJSA-M 0.000 claims description 3
- 239000003513 alkali Substances 0.000 claims description 3
- 229910001854 alkali hydroxide Inorganic materials 0.000 claims description 3
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 claims description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 3
- CAMXVZOXBADHNJ-UHFFFAOYSA-N ammonium nitrite Chemical compound [NH4+].[O-]N=O CAMXVZOXBADHNJ-UHFFFAOYSA-N 0.000 claims description 3
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims description 3
- 235000015165 citric acid Nutrition 0.000 claims description 3
- 229910052742 iron Inorganic materials 0.000 claims description 3
- 239000004310 lactic acid Substances 0.000 claims description 3
- 235000014655 lactic acid Nutrition 0.000 claims description 3
- OVEHNNQXLPJPPL-UHFFFAOYSA-N lithium;n-propan-2-ylpropan-2-amine Chemical compound [Li].CC(C)NC(C)C OVEHNNQXLPJPPL-UHFFFAOYSA-N 0.000 claims description 3
- 239000001630 malic acid Substances 0.000 claims description 3
- 235000011090 malic acid Nutrition 0.000 claims description 3
- KUDPGZONDFORKU-UHFFFAOYSA-N n-chloroaniline Chemical compound ClNC1=CC=CC=C1 KUDPGZONDFORKU-UHFFFAOYSA-N 0.000 claims description 3
- 239000002798 polar solvent Substances 0.000 claims description 3
- 239000004304 potassium nitrite Substances 0.000 claims description 3
- 235000010289 potassium nitrite Nutrition 0.000 claims description 3
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 3
- 235000019260 propionic acid Nutrition 0.000 claims description 3
- 150000004040 pyrrolidinones Chemical class 0.000 claims description 3
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 3
- 239000011975 tartaric acid Substances 0.000 claims description 3
- 235000002906 tartaric acid Nutrition 0.000 claims description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims description 2
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 2
- 229910017052 cobalt Inorganic materials 0.000 claims description 2
- 239000010941 cobalt Substances 0.000 claims description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims description 2
- 229910052741 iridium Inorganic materials 0.000 claims description 2
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052759 nickel Inorganic materials 0.000 claims description 2
- 235000006408 oxalic acid Nutrition 0.000 claims description 2
- 229910052763 palladium Inorganic materials 0.000 claims description 2
- 229910052697 platinum Inorganic materials 0.000 claims description 2
- 229910052703 rhodium Inorganic materials 0.000 claims description 2
- 239000010948 rhodium Substances 0.000 claims description 2
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 claims description 2
- 229910052707 ruthenium Inorganic materials 0.000 claims description 2
- 229910052718 tin Inorganic materials 0.000 claims description 2
- 239000011135 tin Substances 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 claims description 2
- 239000011701 zinc Substances 0.000 claims description 2
- RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical class ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 claims 6
- JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 claims 4
- XKEFYDZQGKAQCN-UHFFFAOYSA-N 1,3,5-trichlorobenzene Chemical class ClC1=CC(Cl)=CC(Cl)=C1 XKEFYDZQGKAQCN-UHFFFAOYSA-N 0.000 claims 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims 2
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 claims 2
- 229940106681 chloroacetic acid Drugs 0.000 claims 2
- 229960005215 dichloroacetic acid Drugs 0.000 claims 2
- 229920001451 polypropylene glycol Polymers 0.000 claims 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 claims 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 claims 1
- 150000001735 carboxylic acids Chemical class 0.000 claims 1
- 150000001805 chlorine compounds Chemical class 0.000 claims 1
- 229940013688 formic acid Drugs 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 150000002823 nitrates Chemical class 0.000 claims 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 claims 1
- 229960004319 trichloroacetic acid Drugs 0.000 claims 1
- 229940116269 uric acid Drugs 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 24
- GBOYJIHYACSLGN-UHFFFAOYSA-N fluopicolide Chemical compound ClC1=CC(C(F)(F)F)=CN=C1CNC(=O)C1=C(Cl)C=CC=C1Cl GBOYJIHYACSLGN-UHFFFAOYSA-N 0.000 abstract description 15
- 239000000543 intermediate Substances 0.000 abstract description 9
- 230000015572 biosynthetic process Effects 0.000 abstract description 6
- WOXFMYVTSLAQMO-UHFFFAOYSA-N 2-Pyridinemethanamine Chemical class NCC1=CC=CC=N1 WOXFMYVTSLAQMO-UHFFFAOYSA-N 0.000 abstract description 5
- 239000005782 Fluopicolide Substances 0.000 abstract description 5
- 238000003786 synthesis reaction Methods 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 3
- 230000000855 fungicidal effect Effects 0.000 abstract description 2
- 239000000417 fungicide Substances 0.000 abstract description 2
- QROKOTBWFZITJZ-UHFFFAOYSA-N n-pyridin-2-ylacetamide Chemical class CC(=O)NC1=CC=CC=N1 QROKOTBWFZITJZ-UHFFFAOYSA-N 0.000 abstract 1
- LNMJFGMGAAFXNW-UHFFFAOYSA-N n-pyridin-2-ylhydroxylamine Chemical class ONC1=CC=CC=N1 LNMJFGMGAAFXNW-UHFFFAOYSA-N 0.000 abstract 1
- 238000006257 total synthesis reaction Methods 0.000 abstract 1
- 239000011541 reaction mixture Substances 0.000 description 42
- 238000004128 high performance liquid chromatography Methods 0.000 description 25
- DIEGHTBYTFRSDU-UHFFFAOYSA-N [3-chloro-5-(trifluoromethyl)pyridin-2-yl]methanamine;hydrochloride Chemical compound Cl.NCC1=NC=C(C(F)(F)F)C=C1Cl DIEGHTBYTFRSDU-UHFFFAOYSA-N 0.000 description 24
- 238000003756 stirring Methods 0.000 description 21
- 239000007787 solid Substances 0.000 description 19
- ABNQGNFVSFKJGI-UHFFFAOYSA-N 2,3-dichloro-5-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CN=C(Cl)C(Cl)=C1 ABNQGNFVSFKJGI-UHFFFAOYSA-N 0.000 description 10
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 9
- 238000001816 cooling Methods 0.000 description 9
- 239000012071 phase Substances 0.000 description 9
- 239000012429 reaction media Substances 0.000 description 9
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 8
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 8
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 8
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 8
- 238000004821 distillation Methods 0.000 description 8
- 238000001035 drying Methods 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 238000001914 filtration Methods 0.000 description 8
- 229910017604 nitric acid Inorganic materials 0.000 description 8
- 238000010979 pH adjustment Methods 0.000 description 8
- 238000001556 precipitation Methods 0.000 description 8
- 238000000746 purification Methods 0.000 description 8
- 238000001953 recrystallisation Methods 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 7
- HITBMJZLAOGWTA-UHFFFAOYSA-N dimethyl 2-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]propanedioate Chemical compound COC(=O)C(C(=O)OC)C1=NC=C(C(F)(F)F)C=C1Cl HITBMJZLAOGWTA-UHFFFAOYSA-N 0.000 description 7
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 7
- 238000005580 one pot reaction Methods 0.000 description 7
- 238000000926 separation method Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 6
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 6
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 6
- KORSBDKODWUAHP-UHFFFAOYSA-N methyl 2-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]acetate Chemical compound COC(=O)CC1=NC=C(C(F)(F)F)C=C1Cl KORSBDKODWUAHP-UHFFFAOYSA-N 0.000 description 6
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 description 5
- BEPAFCGSDWSTEL-UHFFFAOYSA-N dimethyl malonate Chemical compound COC(=O)CC(=O)OC BEPAFCGSDWSTEL-UHFFFAOYSA-N 0.000 description 5
- 229940113088 dimethylacetamide Drugs 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 description 4
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 4
- 125000002015 acyclic group Chemical group 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 125000004122 cyclic group Chemical group 0.000 description 4
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 4
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 4
- SHFJWMWCIHQNCP-UHFFFAOYSA-M hydron;tetrabutylazanium;sulfate Chemical compound OS([O-])(=O)=O.CCCC[N+](CCCC)(CCCC)CCCC SHFJWMWCIHQNCP-UHFFFAOYSA-M 0.000 description 4
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 239000012265 solid product Substances 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 125000004430 oxygen atom Chemical group O* 0.000 description 3
- RELMFMZEBKVZJC-UHFFFAOYSA-N 1,2,3-trichlorobenzene Chemical compound ClC1=CC=CC(Cl)=C1Cl RELMFMZEBKVZJC-UHFFFAOYSA-N 0.000 description 2
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 2
- JBLIDPPHFGWTKU-UHFFFAOYSA-N 2,6-dichlorobenzoyl chloride Chemical compound ClC(=O)C1=C(Cl)C=CC=C1Cl JBLIDPPHFGWTKU-UHFFFAOYSA-N 0.000 description 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- OKIZCWYLBDKLSU-UHFFFAOYSA-M N,N,N-Trimethylmethanaminium chloride Chemical compound [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 2
- 239000000920 calcium hydroxide Substances 0.000 description 2
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 2
- WJTCGQSWYFHTAC-UHFFFAOYSA-N cyclooctane Chemical compound C1CCCCCCC1 WJTCGQSWYFHTAC-UHFFFAOYSA-N 0.000 description 2
- 239000004914 cyclooctane Substances 0.000 description 2
- 229940117389 dichlorobenzene Drugs 0.000 description 2
- ISOLMABRZPQKOV-UHFFFAOYSA-N diethyl 2-acetamidopropanedioate Chemical compound CCOC(=O)C(NC(C)=O)C(=O)OCC ISOLMABRZPQKOV-UHFFFAOYSA-N 0.000 description 2
- UKFXDFUAPNAMPJ-UHFFFAOYSA-N ethylmalonic acid Chemical compound CCC(C(O)=O)C(O)=O UKFXDFUAPNAMPJ-UHFFFAOYSA-N 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- ZRLVUNNBSSUWAC-UHFFFAOYSA-M hydrogen sulfate;tetraoctylazanium Chemical compound OS([O-])(=O)=O.CCCCCCCC[N+](CCCCCCCC)(CCCCCCCC)CCCCCCCC ZRLVUNNBSSUWAC-UHFFFAOYSA-M 0.000 description 2
- MOXJKKOSZCHGEU-UHFFFAOYSA-M hydrogen sulfate;tetrapropylazanium Chemical compound OS([O-])(=O)=O.CCC[N+](CCC)(CCC)CCC MOXJKKOSZCHGEU-UHFFFAOYSA-M 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- CREVBWLEPKAZBH-UHFFFAOYSA-M hydron;tetraethylazanium;sulfate Chemical compound OS([O-])(=O)=O.CC[N+](CC)(CC)CC CREVBWLEPKAZBH-UHFFFAOYSA-M 0.000 description 2
- DWTYPCUOWWOADE-UHFFFAOYSA-M hydron;tetramethylazanium;sulfate Chemical compound C[N+](C)(C)C.OS([O-])(=O)=O DWTYPCUOWWOADE-UHFFFAOYSA-M 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- SKTCDJAMAYNROS-UHFFFAOYSA-N methoxycyclopentane Chemical compound COC1CCCC1 SKTCDJAMAYNROS-UHFFFAOYSA-N 0.000 description 2
- ZIYVHBGGAOATLY-UHFFFAOYSA-N methylmalonic acid Chemical compound OC(=O)C(C)C(O)=O ZIYVHBGGAOATLY-UHFFFAOYSA-N 0.000 description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 239000003880 polar aprotic solvent Substances 0.000 description 2
- GAPYKZAARZMMGP-UHFFFAOYSA-N pyridin-1-ium;acetate Chemical compound CC(O)=O.C1=CC=NC=C1 GAPYKZAARZMMGP-UHFFFAOYSA-N 0.000 description 2
- BBFCIBZLAVOLCF-UHFFFAOYSA-N pyridin-1-ium;bromide Chemical compound Br.C1=CC=NC=C1 BBFCIBZLAVOLCF-UHFFFAOYSA-N 0.000 description 2
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 2
- YWVYZMVYXAVAKS-UHFFFAOYSA-N pyridin-1-ium;trifluoromethanesulfonate Chemical compound C1=CC=[NH+]C=C1.[O-]S(=O)(=O)C(F)(F)F YWVYZMVYXAVAKS-UHFFFAOYSA-N 0.000 description 2
- HWCKGOZZJDHMNC-UHFFFAOYSA-M tetraethylammonium bromide Chemical compound [Br-].CC[N+](CC)(CC)CC HWCKGOZZJDHMNC-UHFFFAOYSA-M 0.000 description 2
- YMBCJWGVCUEGHA-UHFFFAOYSA-M tetraethylammonium chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC YMBCJWGVCUEGHA-UHFFFAOYSA-M 0.000 description 2
- UQFSVBXCNGCBBW-UHFFFAOYSA-M tetraethylammonium iodide Chemical compound [I-].CC[N+](CC)(CC)CC UQFSVBXCNGCBBW-UHFFFAOYSA-M 0.000 description 2
- DDFYFBUWEBINLX-UHFFFAOYSA-M tetramethylammonium bromide Chemical compound [Br-].C[N+](C)(C)C DDFYFBUWEBINLX-UHFFFAOYSA-M 0.000 description 2
- RXMRGBVLCSYIBO-UHFFFAOYSA-M tetramethylazanium;iodide Chemical compound [I-].C[N+](C)(C)C RXMRGBVLCSYIBO-UHFFFAOYSA-M 0.000 description 2
- QBVXKDJEZKEASM-UHFFFAOYSA-M tetraoctylammonium bromide Chemical compound [Br-].CCCCCCCC[N+](CCCCCCCC)(CCCCCCCC)CCCCCCCC QBVXKDJEZKEASM-UHFFFAOYSA-M 0.000 description 2
- SNNIPOQLGBPXPS-UHFFFAOYSA-M tetraoctylazanium;chloride Chemical compound [Cl-].CCCCCCCC[N+](CCCCCCCC)(CCCCCCCC)CCCCCCCC SNNIPOQLGBPXPS-UHFFFAOYSA-M 0.000 description 2
- KGPZZJZTFHCXNK-UHFFFAOYSA-M tetraoctylazanium;iodide Chemical compound [I-].CCCCCCCC[N+](CCCCCCCC)(CCCCCCCC)CCCCCCCC KGPZZJZTFHCXNK-UHFFFAOYSA-M 0.000 description 2
- BGQMOFGZRJUORO-UHFFFAOYSA-M tetrapropylammonium bromide Chemical compound [Br-].CCC[N+](CCC)(CCC)CCC BGQMOFGZRJUORO-UHFFFAOYSA-M 0.000 description 2
- FBEVECUEMUUFKM-UHFFFAOYSA-M tetrapropylazanium;chloride Chemical compound [Cl-].CCC[N+](CCC)(CCC)CCC FBEVECUEMUUFKM-UHFFFAOYSA-M 0.000 description 2
- GKXDJYKZFZVASJ-UHFFFAOYSA-M tetrapropylazanium;iodide Chemical compound [I-].CCC[N+](CCC)(CCC)CCC GKXDJYKZFZVASJ-UHFFFAOYSA-M 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- ONQBOTKLCMXPOF-UHFFFAOYSA-N 1-ethylpyrrolidine Chemical compound CCN1CCCC1 ONQBOTKLCMXPOF-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- FFNVQNRYTPFDDP-UHFFFAOYSA-N 2-cyanopyridine Chemical class N#CC1=CC=CC=N1 FFNVQNRYTPFDDP-UHFFFAOYSA-N 0.000 description 1
- WWYDYZMNFQIYPT-UHFFFAOYSA-L 2-phenylpropanedioate Chemical compound [O-]C(=O)C(C([O-])=O)C1=CC=CC=C1 WWYDYZMNFQIYPT-UHFFFAOYSA-L 0.000 description 1
- ZBJOEDMVIJBOHP-UHFFFAOYSA-N 3-(2-bromoethoxy)-3-oxopropanoic acid Chemical compound OC(=O)CC(=O)OCCBr ZBJOEDMVIJBOHP-UHFFFAOYSA-N 0.000 description 1
- FSUGVSPICFHONS-UHFFFAOYSA-N 3-(3-bromopropoxy)-3-oxopropanoic acid Chemical compound C(COC(=O)CC(=O)O)CBr FSUGVSPICFHONS-UHFFFAOYSA-N 0.000 description 1
- KTKQWOLKKFDOPC-UHFFFAOYSA-N 3-(6-chlorohexoxy)-3-oxopropanoic acid Chemical compound OC(=O)CC(=O)OCCCCCCCl KTKQWOLKKFDOPC-UHFFFAOYSA-N 0.000 description 1
- VOINABWTAQBTDO-UHFFFAOYSA-N 3-(bromomethoxy)-3-oxopropanoic acid Chemical compound OC(CC(OCBr)=O)=O VOINABWTAQBTDO-UHFFFAOYSA-N 0.000 description 1
- IZTZWJGUGIPLAE-UHFFFAOYSA-N 3-(chloromethoxy)-3-oxopropanoic acid Chemical compound ClCOC(CC(=O)O)=O IZTZWJGUGIPLAE-UHFFFAOYSA-N 0.000 description 1
- OMHQOKGHQPULBU-UHFFFAOYSA-N 3-cyclohexyloxy-3-oxopropanoic acid Chemical compound OC(=O)CC(=O)OC1CCCCC1 OMHQOKGHQPULBU-UHFFFAOYSA-N 0.000 description 1
- FJDPQEWILQPYAK-UHFFFAOYSA-N 3-hexoxy-3-oxopropanoic acid Chemical compound CCCCCCOC(=O)CC(O)=O FJDPQEWILQPYAK-UHFFFAOYSA-N 0.000 description 1
- ZYSZVGWQXGCPID-UHFFFAOYSA-N 3-o-chloro 1-o-ethyl propanedioate Chemical compound CCOC(=O)CC(=O)OCl ZYSZVGWQXGCPID-UHFFFAOYSA-N 0.000 description 1
- HDXXKLJVUKAUHH-UHFFFAOYSA-N 3-oxo-3-propoxypropanoic acid Chemical compound CCCOC(=O)CC(O)=O HDXXKLJVUKAUHH-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- FIWILGQIZHDAQG-UHFFFAOYSA-N NC1=C(C(=O)NCC2=CC=C(C=C2)OCC(F)(F)F)C=C(C(=N1)N)N1N=C(N=C1)C1(CC1)C(F)(F)F Chemical compound NC1=C(C(=O)NCC2=CC=C(C=C2)OCC(F)(F)F)C=C(C(=N1)N)N1N=C(N=C1)C1(CC1)C(F)(F)F FIWILGQIZHDAQG-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- GSYGVPZOXIORNA-UHFFFAOYSA-N OC(=O)CC(=O)OCCCCl Chemical compound OC(=O)CC(=O)OCCCCl GSYGVPZOXIORNA-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- JVQYWHGODHSTAM-UHFFFAOYSA-N [3-chloro-5-(trifluoromethyl)pyridin-2-yl]methanamine Chemical compound NCC1=NC=C(C(F)(F)F)C=C1Cl JVQYWHGODHSTAM-UHFFFAOYSA-N 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- UKXSKSHDVLQNKG-UHFFFAOYSA-N benzilic acid Chemical compound C=1C=CC=CC=1C(O)(C(=O)O)C1=CC=CC=C1 UKXSKSHDVLQNKG-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- XXBDWLFCJWSEKW-UHFFFAOYSA-N dimethylbenzylamine Chemical compound CN(C)CC1=CC=CC=C1 XXBDWLFCJWSEKW-UHFFFAOYSA-N 0.000 description 1
- SXZIXHOMFPUIRK-UHFFFAOYSA-N diphenylmethanimine Chemical class C=1C=CC=CC=1C(=N)C1=CC=CC=C1 SXZIXHOMFPUIRK-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- NMCUIPGRVMDVDB-UHFFFAOYSA-L iron dichloride Chemical class Cl[Fe]Cl NMCUIPGRVMDVDB-UHFFFAOYSA-L 0.000 description 1
- MVFCKEFYUDZOCX-UHFFFAOYSA-N iron(2+);dinitrate Chemical class [Fe+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O MVFCKEFYUDZOCX-UHFFFAOYSA-N 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- IDNHOWMYUQKKTI-UHFFFAOYSA-M lithium nitrite Chemical compound [Li+].[O-]N=O IDNHOWMYUQKKTI-UHFFFAOYSA-M 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 150000002690 malonic acid derivatives Chemical class 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- DYUWTXWIYMHBQS-UHFFFAOYSA-N n-prop-2-enylprop-2-en-1-amine Chemical compound C=CCNCC=C DYUWTXWIYMHBQS-UHFFFAOYSA-N 0.000 description 1
- QMMRZOWCJAIUJA-UHFFFAOYSA-L nickel dichloride Chemical class Cl[Ni]Cl QMMRZOWCJAIUJA-UHFFFAOYSA-L 0.000 description 1
- IPLJNQFXJUCRNH-UHFFFAOYSA-L nickel(2+);dibromide Chemical class [Ni+2].[Br-].[Br-] IPLJNQFXJUCRNH-UHFFFAOYSA-L 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- RAFRTSDUWORDLA-UHFFFAOYSA-N phenyl 3-chloropropanoate Chemical compound ClCCC(=O)OC1=CC=CC=C1 RAFRTSDUWORDLA-UHFFFAOYSA-N 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000003032 phytopathogenic effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 125000005415 substituted alkoxy group Chemical group 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- VPYJNCGUESNPMV-UHFFFAOYSA-N triallylamine Chemical compound C=CCN(CC=C)CC=C VPYJNCGUESNPMV-UHFFFAOYSA-N 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
Definitions
- the present invention refers to new key intermediates for the preparation of pyridylmethylbenzamides, and corresponded preparation processes thereof.
- the invention directed to a novel approach for the preparation of pyridylmethylbenzamides, in particular, Fluopicolide.
- X is halogen, C1-C4 alkyl or C1-C4 haloalkyl
- Y is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 q is 0-5 are well known for their activity against phytopathogenic fungi and are extensively used in the agriculture industry as pesticide.
- Bayer Ltd were the first to describe fluopicolide, (2,6-Dichloro- N- ⁇ [3-chloro-5-(trifluoromethyl)-2-pyridyl]methyl ⁇ benzamide), and its family of compounds of formula (VIII) in EP1056723.
- compounds, and the synthesis via substituted 2- (aminomethyl)pyridine derivatives, a key intermediate in the synthesis were disclosed.
- WO 1999/042447 and WO 2004/065359 display a process for the preparation of 2- aminomethylpyridine via benzophenone imine derivatives.
- this method has low economic efficiency, low yields, and high cost.
- WO 2002/016322, and WO 2004/046114 display the preparation of substituted 2- (aminomethyl)pyridine derivatives by hydrogenation of the corresponding substituted 2- cyanopyridine derivatives in the presence of metal catalyst.
- this method results in low yield of the hydrogenation step, the formation of dehalogenated side products and the formation of secondary and tertiary amines which contaminate the desired primary amine.
- this method is costly, inefficient, and occasionally leads to metal contamination in the final product.
- Preparative methods for these compounds must be improved for economic commercial operation.
- the present invention makes available a convenient, cost-effective route, to prepare substituted 2-(aminomethyl)pyridine derivatives and its corresponded pyridylmethylbenzamides. Summary
- the present invention is directed to a compound of formula (I), wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
- Z is optionally halogen substituted C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO ⁇ R; wherein R is -CH3, -C6H5-CH3; p is 0-4 and more specifically to a compound of formula (la) also, related to the method of preparing of a compound of formula (I) wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
- Z is optionally halogen substituted C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO ⁇ R; wherein R is -CH3, -C6H5-CH3; p is 0-4 comprising reaction of a compound of formula (II) or its salts thereof wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
- Z is optionally halogen substituted C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO ⁇ R; wherein R is -CH3, -C6H5-CH3; p is 0-4 with nitrite salt selected from the group comprising sodium nitrite, potassium nitrite, ammonium nitrite and the mixture thereof, in the presence of acid, optionally in the presence of a solvent, optionally in the presence of phase transfer catalyst.
- Another aspect of the present invention is related to the method of preparing of a compound of formula (II) or its salts thereof wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
- Z is optionally halogen substituted C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO ⁇ R; wherein R is -CH3, -C6H5-CH3; p is 0-4 comprising reaction of a compound of formula (III) or its salts thereof wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
- Z 1 , Z 2 are independently, optionally halogen substituted C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO ⁇ R; wherein R is -CH3, -C6H5-CH3; p is 0-4 in the presence of an acid selected form the group consisting of trifluoroacetic acid, hydrochloric acid, hydrobromic acid, sulfuric acid, methane sulfonic acid, para-toluene sulfonic acid, phosphoric acid.
- an alkaline metal halides selected from a group comprising sodium chloride, potassium chloride, lithium chloride, sodium bromide, potassium bromide, lithium bromide,
- the present invention is related to the method of preparing of a compound of formula
- Z 1 , Z 2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO ⁇ R; wherein R is -CH3, -C6H5-CH3; p is 0-4 comprising reaction of a compound of formula (IV) wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 with a compound of formula A ( A,
- Z 1 , Z 2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO ⁇ R; wherein R is -CH3, -C6H5-CH3; in the presence of a base and a phase transfer catalyst.
- the present invention is also related to the method of preparing of a compound of formula (II) or its salts thereof wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl; Z is optionally halogen substituted C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO ⁇ R; wherein R is -CH3, -C6H5-CH3; p is 0-4 comprising heating of a compound of formula (III) or its salts thereof wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
- Z 1 , Z 2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO ⁇ R; wherein R is -CH3, -C6H5-CH3; p is 0-4 at 60-180°C under pressure of 1-32 bars.
- the present invention further provides a process of preparing of a compound of formula (V) or its salts thereof wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
- Z is, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO ⁇ R; wherein R is -CH3, -C6H5-CH3; p is 0-4 comprising reaction of compound of a formula (I) wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl; Z is, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO ⁇ R; wherein R is -CH3, -C6H5-CH3; p is 0-4 with hydrogen in the presence of metal catalyst, optionally in the presence of acid.
- Another aspect of the present invention is related to the method of preparing a compound of formula (VI) or its salts thereof wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 comprising a) preparing a compound of formula (V) according to above methods and b) further reaction of resulting a compound of formula (V) with an acid, optionally in the presence of organic solvent.
- the present invention additionally provides a method of preparing of a compound of formula (VIII) wherein
- X is halogen, C1-C4 alkyl or C1-C4 haloalkyl
- Y is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 q is 0-5 comprising reaction of a compound of formula (VI) prepared according to the above method with a compound of formula (VII) wherein q is an integer equal to 1, 2, 3 or 4, Y is halogen and
- L is a leaving group selected from C1-C6 alkoxy, OH, halogens, hydrogen, OSfO ⁇ R wherein R is - CH 3 , -C 6 H 5 -CH 3 ; q is 0-5 in the presence of organic solvent, optionally in the presence of base.
- the present invention is further related to the method of preparing of a compound of formula (VIII) wherein
- X is halogen, C1-C4 alkyl or C1-C4 haloalkyl
- Y is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 q is 0-5 using the compound of formula (I) wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
- Z is, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO ⁇ R; wherein R is -CH 3 , -CeHs-CHs; p is 0-4
- Another aspect of the present invention is related to a compound of formula (XI), wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
- Z 1 , Z 2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO ⁇ R; wherein R is -CH3, -C6H5-CH3; p is 0-4 and more specifically to a compound of formula (Xia),
- the present invention further provides a method for preparing a compound of formula (XI), wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
- Z 1 , Z 2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO ⁇ R; wherein R is -CH3, -C6H5-CH3; p is 0-4 comprising reaction of a compound of formula (IX) wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 with a compound of formula (X) wherein Z 1 , Z 2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO ⁇ R; wherein R is -CH3, -C6H5-CH3; in the presence of organic solvent, optionally in
- the present invention provides the method for the preparing a compound of formula (VI), or its salts thereof wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 comprising preparing a compound of formula (XI) according to above method with an acid, optionally in the presence of organic solvent.
- Another aspect of the present invention is related to the method of preparing a compound of formula (VIII) wherein
- X is halogen, C1-C4 alkyl or C1-C4 haloalkyl
- Y is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 q is 0-5 comprising reaction of a compound of formula (VI) prepared according to the above method with a compound of formula (VII) wherein q is an integer equal to 1, 2, 3 or 4,
- Y is halogen
- L is a leaving group selected from C1-C6 alkoxy, OH, halogens, hydrogen, OSfO ⁇ R; wherein R is - CH 3 , -C 6 H 5 -CH 3 ; q is 0-5
- the present invention is correlated to the method of preparing of a compound of formula (VIII) wherein
- X is halogen, C1-C4 alkyl or C1-C4 haloalkyl
- Y is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 q is 0-5 using the compound of formula (XI) wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl; wherein Z 1 , Z 2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO R; wherein R is -CH3, -C6H5-CH3; p is 0-4
- halogen or "halo” as used herein refers to one or more halogen atoms, defined as F, Cl, Br, and I.
- numerical parameters set forth in the following specification and attached claims are approximations that may vary depending upon the desired properties sought to be obtained.
- all numbers expressing quantities, percentages, or proportions, and other numerical values used in the specification and claims are to be understood as being modified in all instances by the term "about.”
- each numerical parameter should at least be construed in light of the number of reported significant digits and by applying ordinary rounding techniques.
- use of the term "about” herein specifically includes ⁇ 10% from the indicated values in the range.
- the endpoints of all ranges directed to the same component or property herein are inclusive of the endpoints, are independently combinable, and include all intermediate points and ranges.
- alkoxy refers to optionally substituted alkyl group attached to the parent molecular moiety through an oxygen atom.
- aryloxy refers to optionally substituted aryl group attached to the parent molecular moiety through an oxygen atom.
- alkoxycarbonyl refers to optionally substituted alkoxy group attached to the parent molecular moiety through a carbonyl group.
- benzyloxy refers to a benzyl group C6H5CH2- attached to the parent molecular moiety through an oxygen atom.
- alkyl refers to a group derived from a straight or branched chain saturated hydrocarbon containing from one to six carbon atoms.
- telescopic process refers to carrying out several reactions without isolating the intermediate products.
- the telescopic process suggests the execution of multiple transformations (including reaction quenches and other workup operations) without the direct isolation of intermediates.
- Telescoped solutions of intermediates can be extracted, filtered (as long as the desired product remains in the filtrate), and solvent exchanged, but the intermediate is ultimately held in solution and carried forward to the subsequent transformation.
- salts refers to organic salts such as chloride, bromide, fluoride, iodide, acetate, hydrogen sulfates, phosphates, formats, nitrate, carbonate etc., or, if applicable, alkaline metal salts such as sodium, potassium, calcium, lithium, cesium, magnesium, barium and the like.
- E/Z isomer refers to chemical compound that have the same chemical formulas, yet are different from one another, geometrically.
- the present invention relates to a new compound of general formula (I): wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
- Z is, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO R; wherein R is -CH3, -C6H5-CH3; p is 0-4
- the compound of formula (I) according to the invention can exist in both E/Z form and in any mixture thereof.
- the present invention represents a new compound of formula (la):
- the compound of formula (la) according to the invention can exist in both E/Z form and in any mixture thereof
- the present invention provides a method for preparing a compound of formula (I) by reaction of a compound of formula (II) or its salts thereof wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
- Z is, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO R; wherein R is -CH3, -C6H5-CH3; p is 0-4 with nitrite salt, optionally in the presence of solvent, optionally in the presence of an acid, optionally in the presence of phase transfer catalyst.
- nitrite salt can be selected from the group comprising sodium nitrite, potassium nitrite, calcium nitrite, lithium nitrite, ammonium nitrite and the mixture thereof, preferably sodium nitrite.
- a molar ratio between compound (II) to nitrite salt can be from about 1:10 to 10:1, preferably from about 1:1 to 1:5, most preferably from 1:1 to 1:1.5.
- the organic solvent is selected from the group consisting of aliphatic hydrocarbons (acyclic and cyclic), such as octane, heptane, hexane, pentane, cyclooctane, cyclopentane, petroleum ether, cyclohexane, cyclopentane, chlorinated hydrocarbons such as, carbon tetrachloride, chloroform, 1,2-dichloroethane, methylene chloride, optionally substituted aromatic hydrocarbons such as toluene, benzene, xylene, ethylbenzene, chlorobenzene, dichlorobenzene, trichlorobenzene, ethers (acyclic and cyclic) such as, diethyl ether, diglyme (diethylene glycol dimethyl ether), 1,4-dioxane, methyl t-butyl ether (MTBE), tetrahydrofuran
- a molar ratio between compound (II) to organic solvent can be from about 1:20 to 10:1, preferably from 1:0.5 to 1:5, most preferably from about 1:3 to 1:5.
- the acid is selected from the group consisting of organic acid, Cl- C6 carboxylic acid, acetic acid, propionic acid, formic acid, benzoic acid, citric acid, glutamic acid, malonic acid, tartaric acid, phthalic acid, barbituric acid, cinnamic acid, glutaric acid, hexanoic acid, malic acid, folic acid, trifluoroacetic acid, ascorbic acid, glutamic acid, benzylic acid, lactic acid, para-toluene sulfonic acid, inorganic acid, such as sulfuric acid, nitric acid, phosphoric acid, carbonic acid, hydrochloric acid, hydrobromic acid, nitric acid, and the mixture thereof.
- a molar ratio between compound (II) to acid can be from about 1:20 to 10:1, preferably from about 1:1 to 1:5, most preferably from about 1:3 to 1:5.
- phase transfer catalyst selected from the group consisting of ammonium salt or polyethers selected from the group consisting of pyridinium hydrochloride, pyridinium acetate, pyridinium triflate, pyridinium hydrobromide, tetrabutylammonium bromide, tetrabutylammonium chloride, tetrabutylammonium fluoride, tetrabutylammonium hydrogen sulfate, tetrabutylammonium iodide, tetraethylammonium bromide, tetraethylammonium chloride, tetraethylammonium hydrogen sulfate, tetraethylammonium iodide, tetramethylammonium bromide, tetramethylammonium chloride, tetramethylammonium hydrogen sulfate, tetramethylammonium iodide,
- a molar ratio between compound (II) to phase transfer catalyst can be from about 1:1 to 1:0.0001, preferably from about 1:0.01 to 1:0.1, most preferably from about 1:0.05 to 1:0.01.
- a preferred temperature interval is from 15 to 50°C., more preferably from 15 to 25°C.
- the nitrite salt can be added to the mixture of compound (II), as a solid or as an aqueous solution.
- a weight ratio between the aqueous solution and the compound (II) mixture can be of from 10:1 and 1:10 w/w, preferably from 0.5:1 to 2:1, most preferably a 1:1 w/w.
- the reaction mixture is allowed to stir between 1 minute to 10 hours according to the reaction progress, preferably from 1 to 2 hours.
- the reaction temperature interval is from 0 to 130°C, preferably from 0 to 50°C, most preferably from 10 to 20°C.
- the reaction mixture is monitored by HPLC analytical method, and the process ends when concentration of formula (II) is between 0-99%, preferably from 0-50%, most preferably, in particular, when no more than 1% of compound of formula (II) remains in the reaction media.
- reaction mixture containing the resulting a compound of formula (I) is worked up.
- This stage may include adding water, adding organic solvent, stirring, cooling, heating, phases separation, distillation, precipitation, recrystallization, concentration, filtration, purification, pH adjustment, extraction, and drying processes.
- the present invention provides a method of preparing a compound of formula (II) or its salts thereof, wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
- Z is, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO ⁇ R; wherein R is -CH3, -C6H5-CH3; p is 0-4 by two-step reaction, which can be performed as separated processes or as combined processes, such as one-pot reaction, telescopic-reaction, preferably, in one-pot reaction process.
- the intermediates formed in the above process can be isolated from the reaction mixture or the process can be continued without isolation of said intermediates.
- the first step provides the method of preparing a compound of formula (III), or its salts thereof, wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
- Z 1 , Z 2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO ⁇ R; wherein R is -CH3, -C6H5-CH3;; p is 0-4 by reaction of a compound of formula (IV) wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 with compound of formula A
- Z 1 , Z 2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO R; wherein R is -CH3, -C6H5-CH3;; in the presence of base, organic solvent, and phase transfer catalyst
- the compound (A) is selected from the group consisting of methyl malonate, ethyl malonate, propyl malonate, hexyl malonate, cyclohexyl malonate, benzyl malonate, chloromethyl malonate, chloroethyl malonate, chloropropyl malonate, chlorohexyl malonate, chlorocyclohexyl malonate, chlororbenzyl malonate, bromomethyl malonate, bromoethyl malonate, bromopropyl malonate, bromohexyl malonate, bromocyclohexyl malonate, bromorbenzyl malonate, malonic acid and the mixtures thereof, preferably, methyl malonate or ethyl malonate.
- a molar ratio between compound (IV) to malonic acid or alkyl malonate can be from about 1:10 to 10:1, preferably from 2:1 to 1:2, most preferably from about 1:1 to 1:1.5
- the base is selected from the group consisting of aluminum hydroxide, calcium hydroxide, calcium hydroxide, iron(ll) hydroxide, lithium hydroxide, potassium hydroxide, ammonium hydroxide, sodium hydroxide, sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate, calcium carbonate, trimethylamine, tributylamine, diisopropylamine, tetrmethylethylendiamine, pyridine, dimethylbenzylamine, quinoline, aniline, imidazole, pyrrole, pyrrolidine, pyrimidine, piperidine, piperazine, morpholine, N-methyl morpholine, N-ethyl pyrrolidine, diisopropylmehtylamine, diisopropylethylamine, triallyl amine, diallyl amine, indole, butyl lithium, sodium hydride, potassium hydride, and the mixtures thereof, preferably, potassium bicarbonate.
- the molar ratio between compound (IV) to the base can be from about 1:10 to 10:1, preferably from 2:1 to 1:5, most preferably from about 1:1 to 1:3.
- the organic solvent is selected from the group consisting of aliphatic hydrocarbons (acyclic and cyclic) such as, octane, heptane, hexane, pentane, cyclooctane, cyclopentane, petroleum ether, cyclohexane, cyclopentane, chlorinated hydrocarbons such as, carbon tetrachloride, chloroform, 1,2-dichloroethane, methylene chloride, aromatic hydrocarbons with or without substitution such as, toluene, benzene, xylene, ethylbenzene, chlorobenzene, dichlorobenzene, trichlorobenzene), all ethers (acyclic and cyclic) such as, diethyl ether, diglyme (diethylene glycol dimethyl ether), 1,4-dioxane, methyl t-butyl ether (MTBE), tetrahydr
- a w/w ratio between compound (IV) to organic solvent can be from about 1:20 to 20:1, preferably from about 1:1 to 1:10, most preferably from about 1:3 to 1:5.
- phase transfer catalyst selected from the group consisting of ammonium salt or polyethers selected from the group consisting of pyridinium hydrochloride, pyridinium acetate, pyridinium triflate, pyridinium hydrobromide, tetrabutylammonium bromide, tetrabutylammonium chloride, tetrabutylammonium fluoride, tetrabutylammonium hydrogen sulfate, tetrabutylammonium iodide, tetraethylammonium bromide, tetraethylammonium chloride, tetraethylammonium hydrogen sulfate, tetraethylammonium iodide, tetramethylammonium bromide, tetramethylammonium chloride, tetramethylammonium hydrogen sulfate, tetramethylammonium iodide,
- a molar ratio between compound (IV) to phase transfer catalyst can be from about 1:1 to 1:0.0001, preferably from about 1:0.1 to 1:0.001, most preferably from about 1:0.05 to 1:0.01
- compound (III) is produced by mixing of a compound of formula (IV), malonic acid or malonate derivative, and base in organic solvent, and heating the mixture to temperature interval from 20 to 130°C, preferably from 50 to 110°C, most preferably from 80 to 100°C.
- the reaction mixture is allowed to stir between 1 to 10 hours according to the reaction progress, preferably from to 10 hours, most preferably from 5 to 7 hours.
- the reaction mixture is monitored by HPLC analytical method and ends when concentration of formula (IV) is between 0-99%, preferably from 0-50%, most preferably, in particular, when no more than 1% of compound of formula (IV) remains in the reaction media.
- reaction mixture containing the resulting a compound of formula (III) is worked up.
- This stage may include, cooling, adding water, adding organic solvent, stirring, cooling, heating, phases separation, distillation, precipitation, recrystallization, concentration, filtration, washing, purification, pH adjustment, extraction, and drying processes.
- a second step which is completed as in one-pot process, comprising the method of preparing a compound of formula (II) or its salts thereof, wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
- Z is, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO R; wherein R is -CH3, -C6H5-CH3; p is 0-4
- a compound of formula (II) is prepared by the process provide the reaction of a compound of formula (III) or its salts thereof wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl,
- Z 1 , Z 2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfOhR; wherein R is -CH3, -C6H5-CH3; p is 0-4 in the presence of an acid, and/or, with an alkaline metal halides
- the acid in the above process is selected from the group consisting of sulfuric acid, nitric acid, phosphoric acid, carbonic acid, hydrochloric acid, hydrobromic acid, nitric acid, and the mixture thereof, preferably, hydrochloric acid.
- a w/w ratio between compound (III) to the acid can be from about 1:0.5 to 1:10, preferably from 1:0.5 to 1:5, most preferably from about 1:1 to 1:2
- the alkaline metal halides is selected from a group consisting of sodium chloride, potassium chloride, lithium chloride, sodium bromide, potassium bromide, lithium bromide, most preferably sodium chloride or potassium chloride
- a w/w ratio between compound (III) to the alkaline metal halides can be from about 1:0.1 to 1:10, preferably from 1:0.5 to 1:5, most preferably from about 1:1.5 to 1:2.5
- compound (II) is produced by mixing of a compound of formula (III), and acid, and heating the mixture to temperature interval from 20 to 130°C, preferably from 100 to 130°C, most preferably from 120 to 130°C.
- the reaction mixture is allowed to stir between 1 to 10 hours according to the reaction progress, preferably from 5 to 10 hours, most preferably from 8 to 9 hours.
- the reaction mixture is monitored by HPLC analytical method and ends when concentration of formula (III) is between 0-99%, preferably from 0-50%, in particular, when no more than 2.5% of compound of formula (III) remains in the reaction media.
- reaction mixture containing the resulting a compound of formula (II) is worked up.
- This stage may include cooling, adding water, adding organic solvent, stirring, heating, phase separation, distillation, precipitation, recrystallization, concentration, filtration, decantation, washing, purification, pH adjustment, extraction, and drying processes.
- Z is, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO R; wherein R is -CH3, -C6H5-CH3; p is 0-4 comprising heating of a compound of formula (III) or its salts thereof wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl; Z 1 , Z 2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO ⁇ R; wherein R is -CH3, -C6H5-CH3; p is 0-4 at high temperature of between 60 to 200°C, preferably from 120 to 180°C, most preferably from
- the reaction mixture is monitored by HPLC analytical method and ends when concentration of formula (III) is between 0-99%, preferably from 0-50%, in particular, when no more than 1% of compound of formula (III) remains in the reaction media.
- the first step provides the method of preparing a compound of formula (V) or its salts thereof, wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
- Z is, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO ⁇ R; wherein R is -CH3, -C6H5-CH3; p is 0-4 comprising reaction of a compound of formula (I) wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
- Z is, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO ⁇ R; wherein R is -CH3, -C6H5-CH3; p is 0-4 with hydrogen in the presence of metal catalyst, optionally in the presence of acid.
- the metal catalyst is selected form the group comprising zinc, iridium, nickel, palladium, platinum, rhodium, or ruthenium, cobalt, tin, iron, Raney Ni, or metal salts selected form the group of iron chlorides, iron nitrates, nickel chlorides, nickel bromides, Grubs catalysts, and the mixtures thereof.
- a w/w ratio between compound (I) to catalyst can be from about 1:1 to 1:0.0001, preferably from 1:0.005 to 1:0.5, most preferably from about 1:0.05 to 1:0.15
- C1-C4 carboxylic acid selected form the group comprising acetic acid, propionic acid, butyric acid, lactic acid, formic acid, citric acid, oxalic acid, malic acid, tartaric acid, and a mixture thereof, preferably, acetic acid.
- a w/w ratio between compound (I) to C1-C4 carboxylic acid can be from about 1:10 to 1:0.5, preferably from 1:10 to 1:1, most preferably from about 1:8 to 1:2
- hydrogen gas at a pressure of between 4-20bar, preferably from 8 to 16 bar, most preferably from about 10-15 bar.
- compound (V) is produced by mixing of a compound of formula (I), and optionally acid, and optionally hydrogen gas and at temperature interval of from 20 to 130°C, preferably from 50 to 100°C, most preferably from 70 to 80°C.
- the reaction mixture is allowed to stir between 1 to 10 hours according to the reaction progress, preferably from 5 to 10 hours, most preferably from 5 to 8 hours.
- the reaction mixture is monitored by HPLC analytical method and ends when concentration of formula (I) is between 0-99%, preferably from 0-50%, in particular, when no more than 1% of compound of formula (I) remains in the reaction media.
- reaction mixture containing the resulting a compound of formula (V) is worked up.
- This stage may include, cooling, adding water, adding organic solvent, stirring, heating, phases separation, distillation, precipitation, recrystallization, concentration, filtration, washing, purification, pH adjustment, extraction, and drying processes.
- the second step comprising the method of preparing a compound of formula (VI), or its salts thereof wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 comprising reaction of a compound of formula (V) wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
- Z is, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO R; wherein R is -CH3, -C6H5-CH3; p is 0-4 in the presence of an acid, optionally in the presence of organic solvent.
- the acid is selected from the group consisting of sulfuric acid, nitric acid, phosphoric acid, carbonic acid, hydrochloric acid, hydrobromic acid, nitric acid, and the mixture thereof, preferably, hydrochloric acid.
- molar ratio between compound (V) to acid can be from about 1:10 to 1:0.5, preferably, from about 1:2 to 1:4.
- the organic solvent is selected from water, dichloromethane, methanol, ethanol, isopropanol, tert-butanol, dimethylformamide, 1,4- dioxane, ethyl acetate, acetonitrile, tetrahydrofuran, acetic acid, toluene, benzene, hexane, cyclohexane, dimethyl sulfoxide, pyridine, diethyl ether, chloroform, 1,2-dichloroethane, acetone, isopropyl acetate, anisole, A/-methyl-2-pyrrolidone, 4-methylmorpholine, nitromethane and the mixtures thereof, preferably, toluene.
- a w/w ratio between compound (V) to organic solvent can be from about 1:10 to 10:1, preferably from 1:1 to 1:5, most preferably from about 1:2 to 1:4.
- compound (VI) is produced by mixing of a compound of formula (V), acid, and organic solvent, and heating the resulting mixture to temperature of from 20 to 130°C, preferably from 50 to 100°C, most preferably from 60 to 70°C.
- the reaction mixture is allowed to stir between 10 minutes to 5 hours according to the reaction progress, preferably from 0.5 to 3 hours, most preferably from 1 to 2 hours.
- the reaction mixture is monitored by HPLC analytical method, and the reaction ends when concentration of formula (V) is 0-99%, preferably 0-50%, in particular, when no more than 2.5% of compound of formula (V) remains in the reaction media.
- reaction mixture containing the resulting a compound of formula (VI) is worked up.
- This stage may include, cooling, adding water, adding organic solvent, stirring, heating, phases separation, distillation, precipitation, recrystallization, concentration, filtration, washing, purification, pH adjustment, extraction, and drying processes.
- the compound of formula (VIII) which is a well-known fungicide compound of the fluopicolide of formula: wherein
- X is halogen, C1-C4 alkyl or C1-C4 haloalkyl
- Y is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 q is 0-5 is prepared by a process provides the steps of a) preparation of compound (VI) as described above via compound of formula (I), b) reaction of compound (VI) with compound of formula (VII) in the presence of organic solvent, optionally in the presence of base.
- q is an integer equal to 1, 2, 3 or 4,
- Y is halogen and L is a leaving group selected from C1-C6 alkoxy, OH, halogens, halide, OSfOhR; wherein R is -CH3, -C 6 H 5 -CH 3 ; q is 0-5
- the base is selected from the group comprising of alkali and alkaline earth metal hydroxides, alkoxides, carbonates and bicarbonates and organic primary, secondary and tertiary amines, such as triethylamine, diisopropylethylamine, pyridine, potassium carbonate, potassium bicarbonate, sodium carbonate, sodium bicarbonate, sodium hydroxide, aniline, chloroaniline and the mixture thereof, preferably sodium hydroxide.
- molar ratio between compound (VI) to base can be from about 1:10 to 1:0.5, preferably 1:1 to 1:5, most preferably from about 1:2 to 1:3
- the organic solvent selected from the group comprising aliphatic cyclic and acyclic hydrocarbons, halogenated aliphatic cyclic and acyclic hydrocarbons, aromatic hydrocarbons, halogenated aromatic hydrocarbons, ethers, aliphatic and aromatic esters, nitriles, ketones, C1-C4 alcohols, n-alkyls protic and aprotic polar solvents such as, dichloromethane, chloroform, pyridine, tetrahydrofuran, dimethylformamide, ethyl acetate, toluene, 1,4-dioxane, diethyl ether, isopropyl acetate, methanol, ethanol, acetonitrile, pyrrolidones, dimethylformamide, dimethylacetamide, dimethyl sulfoxide, water and the mixtures thereof, preferably toluene.
- aliphatic cyclic and acyclic hydrocarbons such as
- w/w ratio between compound (VI) to solvent can be from about 1:1 to 1:20, preferably 1:1 to 1:5, most preferably from about 1:2 to 1:3
- base can be added as solid or as an aqueous solution of between 1% to 60% w/w, preferably as aqueous solution of about 2 to 20% w/w, most preferably 5 to 10% w/w.
- w/w ratio between compound (VI) to aqueous base solution can be from about 1:001 to 1:1, preferably from about 1:0.01 to 1:0.5, most preferably from about 1:0.05 to 1:0.15.
- the compound of formula (VII) preferably contacted with the compound of formula (VI), at raised temperature.
- a preferred temperature interval is from 0 to 130°C, preferably from 0 to 50°C, most preferably from 10 to 20°C.
- reaction mixture is allowed to stir for 1 minute to 10 hours after completion of the addition, preferably for 10 minutes to 5 hours, most preferably for 1 to 2 hours.
- reaction temperature interval of the stirring phase is from 0 to 130°C, preferably from 10 to 50°C, most preferably from 20 to 30°C.
- reaction mixture is monitored by HPLC analytical method and ends when concentration of formula (VI) is between 0-99%, preferably from 0-50%, in particular, when no more than 0.5% of compound of formula (VI) remains in the reaction media.
- reaction mixture containing the resulting a compound of formula (VIII) is worked up.
- This stage may include adding water, adding organic solvent, stirring, cooling, heating, phases separation, distillation, precipitation, recrystallization, concentration, filtration, purification, pH adjustment, extraction, and drying processes.
- the present invention relates to a new derivative of general formula (XI) wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
- Z 1 , Z 2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO ⁇ R; wherein R is -CH3, -C6H5-CH3; p is 0-4 and more specifically to a compound of formula (Xia),
- the present invention provides a method of preparing a compound of formula (VI) or its salts thereof, wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 via two steps reaction which can be performed as separate processes or as combined process, such as one-pot reaction, telescopic-reaction, preferably, in one-pot reaction process, is displayed.
- the first step comprising the method of preparing of a compound of formula (XI) wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
- Z 1 , Z 2 are independently, optionally halogen substituted C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO ⁇ R; wherein R is -CH3, -C6H5-CH3; p is 0-4 by reaction of a compound of formula (IV) wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 with a compound of formula (X)
- Z 1 , Z 2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO R; wherein R is -CH3, -C6H5-CH3; in the presence of organic solvent, optionally in the presence of base, and optionally in the presence of phase transfer catalyst.
- a molar ratio between compound (IV) to compound (X) can be from about 1:10 to 10:1, preferably 1:0.5 to 1:5, most preferably from about 1:1 to 1:2.
- base is selected from the group comprising of triethylamine, diisopropylethylamine, pyridine, potassium carbonate, potassium bicarbonate, sodium carbonate, sodium bicarbonate, sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium alkoxide, potassium alkoxide, potassium tert-butoxide, sodium hydride, potassium hydride, butyl lithium, lithium diisopropyl amine, aniline, p-chloroaniline and the mixtures thereof, preferably potassium carbonate.
- a molar ratio between compound (IV) to the base can be from about 1:5 to 0.5:1.0, preferably from about 1:1 to 1:5, most preferably from about 1:1.5 to 1:2.5.
- organic solvent selected from dichloromethane, chloroform, pyridine, water, tetrahydrofuran, dimethyl sulfoxide, N-methyl pyrrolidone, dimethylformamide, ethyl acetate, toluene, 1,4-dioxane, diethyl ether, isopropyl acetate, methanol, ethanol, acetonitrile, dimethylacetamide and the mixtures thereof, preferably dimethyl sulfoxide.
- a w/w ratio between compound (IV) to solvent can be from about 1:20 to 1:0.1, preferably from about 1:1 to 1:10, most preferably from about 1:3 to 1:5.
- phase transfer catalyst selected from the group comprising of quaternary ammonium salts, phosphonium salts, polyether's and the mixtures thereof, such as benzyltriethylammonium chloride, methyltricaprylammonium chloride, methyltributylammonium chloride, and methyltrioctylammonium chloride, tetra-n- butylammoniumchloride, tetra-n-butylammonium bromide tetra-n-butylammonium iodide tetra-n-butylammonium fluoride, crown ethers, polyethylene glycols and the mixture thereof, preferably, tetra-n-butylammonium bromide.
- quaternary ammonium salts such as benzyltriethylammonium chloride, methyltricaprylammonium chloride, methyltributylammonium chloride, and methyltriocty
- a molar ratio between compound (IV) to phase transfer catalyst can be from about 1:1 to 1:0.0001, preferably 1:0.25 to 1:0.025, most preferably from about 1:0.15 to 1:0.05
- the second step provides the method of preparing of a compound of formula (VI) or its salts thereof, wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 comprising reaction of a compound of formula (XI) wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
- Z 1 , Z 2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO ⁇ R; wherein R is -CH3, -C6H5-CH3; p is 0-4 in the presence of acid optionally in the presence of organic solvent.
- the acid is selected from the group consisting of sulfuric acid, nitric acid, phosphoric acid, carbonic acid, hydrochloric acid, hydrobromic acid, nitric acid, and the mixture thereof, preferably, hydrochloric acid.
- molar ratio between compound (XI) to the acid can be from about 1:10 to 1:0.5, preferably from about 1:1 to 1:10, mot preferably from about 1:4 to 1:6.
- the organic solvent is selected organic solvent selected from water, dichloromethane, methanol, ethanol, isopropanol, tert-butanol, dimethylformamide, 1,4- dioxane, ethyl acetate, acetonitrile, tetrahydrofuran, acetic acid, toluene, benzene, hexane, cyclohexane, dimethyl sulfoxide, pyridine, diethyl ether, chloroform, 1,2-dichloroethane, acetone, isopropyl acetate, anisole, A/-methyl-2-pyrrolidone, 4-methylmorpholine, nitromethane and the mixtures thereof, preferably, toluene.
- organic solvent selected from water, dichloromethane, methanol, ethanol, isopropanol, tert-butanol, dimethylformamide, 1,4- dioxane, ethyl a
- a w/w ratio between compound (XI) to the organic solvent can be from about 1:10 to 10:0.1, preferably from ,1:10 to 1:1, most preferably from about 1:5 to 1:1.
- compound (VI) is produced by mixing of a compound of formula (XI), acid, and organic solvent, and heating the mixture to temperature interval from 0 to 130°C, preferably from 50 to 120°C, most preferably from 100 to 115°C.
- the reaction mixture is allowed to stir between 10 minutes to 20 hours according to the reaction progress, preferably from 5 to 15 hours, most preferably from 12 to 15 hours.
- the reaction mixture is monitored by HPLC analytical method and ends when concentration of formula (XI) is 0-99%, preferably 0-50%, in particular, when no more than 2.0% of compound of formula (XI) remains in the reaction media.
- reaction mixture containing the resulting compound of formula (XI) is worked up.
- This stage may include, cooling, adding water, adding organic solvent, stirring, heating, phases separation, distillation, precipitation, recrystallization, concentration, filtration, washing, purification, pH adjustment, extraction, and drying processes.
- X is halogen, C1-C4 alkyl or C1-C4 haloalkyl
- Y is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 q is 0-5 is prepared by a process comprising the steps of: a) preparation of compound (VI) as described above via compound of formula (XI) b) reaction of compound (VI) with compound of formula (VII) in the presence of organic solvent, optionally in the presence of base.
- q is an integer equal to 1, 2, 3 or 4,
- Y is halogen
- L is a leaving group selected from C1-C6 alkoxy, OH, halogens, halide, OSfO ⁇ R; wherein R is -CH3, -C 6 H 5 -CH 3 ; q is 0-5
- the base is selected from the group comprising of alkali and alkaline earth metal hydroxides, alkoxides, carbonates and bicarbonates and organic primary, secondary and tertiary amines, such as triethylamine, diisopropylethylamine, pyridine, potassium carbonate, potassium bicarbonate, sodium carbonate, sodium bicarbonate, sodium hydroxide, aniline, chloroaniline and the mixture thereof, preferably sodium hydroxide.
- molar ratio between compound (VI) to base can be from about 1:10 to 1:0.5, preferably 1:1 to 1:5, most preferably from about 1:2 to 1:3
- the organic solvent selected from the group comprising aliphatic cyclic and acyclic hydrocarbons, halogenated aliphatic cyclic and acyclic hydrocarbons, aromatic hydrocarbons, halogenated aromatic hydrocarbons, ethers, aliphatic and aromatic esters, nitriles, ketones, C1-C4 alcohols, n-alkyls protic and aprotic polar solvents such as, dichloromethane, chloroform, pyridine, tetrahydrofuran, dimethylformamide, ethyl acetate, toluene, 1,4-dioxane, diethyl ether, isopropyl acetate, methanol, ethanol, acetonitrile, pyrrolidones, dimethylformamide, dimethylacetamide, dimethyl sulfoxide, water and the mixtures thereof, preferably toluene.
- aliphatic cyclic and acyclic hydrocarbons such as
- w/w ratio between compound (VI) to solvent can be from about 1:1 to 1:20, preferably 1:1 to 1:5, most preferably from about 1:2 to 1:3
- base can be added as solid or as an aqueous solution of from 1% to 60% w/w, preferably as aqueous solution of from 2 to 20% w/w, most preferably from 5 to 10% w/w.
- w/w ratio between compound (VI) to aqueous base solution can be from about 1:001 to 1:1, preferably from about 1:0.01 to 1:0.5, most preferably from about 1:0.05 to 1:0.15.
- the compound of formula (VII) preferably contacted with the compound of formula (VI), at raised temperature.
- a preferred temperature interval is from 0 to 130°C, preferably from 0 to 50°C, most preferably from 10 to 20°C.
- reaction mixture is allowed to stir for 1 minute to 10 hours after completion of the addition, preferably for 10 minutes to 5 hours, most preferably for 1 to 2 hours.
- reaction temperature interval of the stirring phase is from 0 to 130°C, preferably from 10 to 50°C, most preferably from 20 to 30°C.
- the reaction mixture is monitored by HPLC analytical method and ends when concentration of formula (VI) is between 0-99%, preferably from 0-50%, in particular, when no more than 0.5% of compound of formula (VI) remains in the reaction media.
- reaction mixture containing the resulting a compound of formula (VIII) is worked up.
- This stage may include adding water, adding organic solvent, stirring, cooling, heating, phases separation, distillation, precipitation, recrystallization, concentration, filtration, purification, pH adjustment, extraction, and drying processes.
- Example 1 Preparation of Methyl 2-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)acetate (compound II) from 2,3-Dichloro-5-(trifluoromethyl)pyridine (compound IV) via Dimethyl-2-(3-chloro-5- (trifluoromethyl)pyridine-2-yl)malonate (compound III):
- reaction progress was monitored by HPLC and ended when compound (IV) was less than 1.5% in the reaction mixture.
- the mixture was cool to 25°C and the pH was adjusted by cone. HCI (160 mL). Solid particles were filtered and washed with Toluene (200 mL) twice. Toluene was distilled out to give compound (III) in dimethyl sulfoxide. The mixture was acidified by cone. HCI to adjust the pH to 2.5. The mixture was heated to 115°C through 16 hours.
- the reaction progress was monitored by HPLC and ended when compound (III) was less than 1.5% in the reaction mixture.
- the mixture was cooled to 25°C and water (400 mL) was added followed by Toluene (200 mL).
- N-methyl-2-pyrrolidone 300 mL
- potassium carbonate 142 gr
- 2,3-Dichloro-5- (trifluoromethyl)pyridine 100 gr was charged to the reactor and mixture was stirred for 15 minutes.
- Dimethyl malonate 77.3 gr was charged to the reactor and mixture was stirred for 15 minutes.
- the reaction was then heated to 75°C for 1 hour. Temperature was increased to 90°C for additional 9h.
- the reaction progress was monitored by HPLC and ended when compound (IV) was less than 1.5% in the reaction mixture.
- the mixture was cool to 25°C and the pH was adjusted by cone. HCI (160 mL). Solid particles were filtered and washed with N-methyl-2-pyrrolidone (200 mL) twice. N-Methyl-2-pyrrolidone was distilled out to give an oily crude product containing compound (III), 92% yield.
- N,N-di methyl acetamide 150 mL
- potassium carbonate 96 gr
- dimethyl malonate 77.4 gr
- tetra-n-butylammonium bromide 7.4 gr
- dimethyl aminopyridine 2.8 gr
- 2,3-Dichloro-5- (trifluoromethyl)pyridine 100 gr was charged to the reactor and mixture was stirred for 15 minutes.
- the reaction was then heated to 90°C for 8 hours.
- the reaction progress was monitored by HPLC and ended when compound (IV) was less than 1.5% in the reaction mixture.
- the mixture was cool to 25°C and the pH was adjusted by cone.
- Example 7 Preparation of Methyl 2-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)acetate (compound II) from Dimethyl-2-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)malonate (compound III):
- Example 8 Preparation of Methyl -2-(3-chloro-5-(trifluoromethyl) pyridine-2-yl)- (hydroxylimine)acetate (compound I) from Methyl 2-(3-chloro-5-(trifluoromethyl) pyridin-2-yl) acetate (compound II):
- Example 10 Preparation of (3-Chloro-5-(trifluoromethyl)pyridin-2-yl)methanamine Hydrochloride (compound VI) from Methyl-2-(3-chloro-5-(trifluoromethyl)pyridine-2-yl)-(hydroxylimine)acetate (compound I) via methyl 2-amino-2-(3-chloro-5-trifluoromehtyl)pyridine-2-yl)acetate (compound V)
- Example 11 Preparation of (3-Chloro-5-(trifluoromethyl)pyridin-2-yl)methanamine Hydrochloride (compound VI) from Methyl-2-(3-chloro-5-(trifluoromethyl)pyridine-2-yl)-(hydroxylimine)acetate (compound I) via methyl 2-amino-2-(3-chloro-5-trifluoromehtyl)pyridine-2-yl)acetate (compound V)
- Example 12 Preparation of (3-Chloro-5-(trifluoromethyl)pyridin-2-yl)methanamine Hydrochloride (compound VI) from 2,3-Dichloro-5-(trifluoro methyl)pyridine (compound IV) & Diethylacetamidomalonate (compound X) via Diethyl-2-acetamido-2-(3-chloro-5- (trifluoromethyl)pyridine-2-yl)malonate (compound XI)
- Example 13 Preparation of 2,6-dichloro-N-((3-chloro-5-(trifluoromethyl)pyridin-2- yl)methyl)benzamide (compound VIII) by 2,6-dichlorobenzoyl chloride (compound VII) & (3-chloro- 5(trifluoromethyl)pyridin-2-yl)methanamine (compound VI)
- compound VIII 2,6-dichlorobenzoyl chloride
- compound VI 3-chloro- 5(trifluoromethyl)pyridin-2-yl)methanamine
Abstract
The present invention relates to new intermediates for the preparation of pyridylmethylbenzamides via substituted hydroxyiminopyridines or acetamidopyridines, and their innovative preparation processes. The invention discloses, in particular, the total synthesis of fluopicolide fungicide. The preparation of the main substances of the fluopicolide synthesis, specifically, substituted pyridine-2-ylmethanamine or its salt, is disclosed via two different synthesis routes, comprises two novel substances.
Description
Title: Process for preparing substituted benzamides
FIELD OF INVENTION:
The present invention refers to new key intermediates for the preparation of pyridylmethylbenzamides, and corresponded preparation processes thereof. In general, the invention directed to a novel approach for the preparation of pyridylmethylbenzamides, in particular, Fluopicolide.
BACKGROUND:
Background of invention
X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Y is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 q is 0-5 are well known for their activity against phytopathogenic fungi and are extensively used in the agriculture industry as pesticide. Bayer Ltd were the first to describe fluopicolide, (2,6-Dichloro- N-{[3-chloro-5-(trifluoromethyl)-2-pyridyl]methyl}benzamide), and its family of compounds of formula (VIII) in EP1056723. In this patent, compounds, and the synthesis via substituted 2- (aminomethyl)pyridine derivatives, a key intermediate in the synthesis, were disclosed. WO 1999/042447 and WO 2004/065359, display a process for the preparation of 2- aminomethylpyridine via benzophenone imine derivatives. However, this method has low economic efficiency, low yields, and high cost.
WO 2002/016322, and WO 2004/046114 display the preparation of substituted 2- (aminomethyl)pyridine derivatives by hydrogenation of the corresponding substituted 2- cyanopyridine derivatives in the presence of metal catalyst. However, this method results in low yield of the hydrogenation step, the formation of dehalogenated side products and the formation of secondary and tertiary amines which contaminate the desired primary amine. In addition, this method is costly, inefficient, and occasionally leads to metal contamination in the final product. Preparative methods for these compounds must be improved for economic commercial operation. In view of that, the present invention makes available a convenient, cost-effective route, to prepare substituted 2-(aminomethyl)pyridine derivatives and its corresponded pyridylmethylbenzamides.
Summary
The present invention is directed to a compound of formula (I),
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z is optionally halogen substituted C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; p is 0-4 and more specifically to a compound of formula (la) also, related to the method of preparing of a compound of formula (I)
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z is optionally halogen substituted C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; p is 0-4 comprising reaction of a compound of formula (II) or its salts thereof
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z is optionally halogen substituted C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; p is 0-4 with nitrite salt selected from the group comprising sodium nitrite, potassium nitrite, ammonium nitrite and the mixture thereof, in the presence of acid, optionally in the presence of a solvent, optionally in the presence of phase transfer catalyst.
Another aspect of the present invention is related to the method of preparing of a compound of formula (II) or its salts thereof
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z is optionally halogen substituted C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; p is 0-4 comprising reaction of a compound of formula (III) or its salts thereof
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z1, Z2 are independently, optionally halogen substituted C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; p is 0-4 in the presence of an acid selected form the group consisting of trifluoroacetic acid, hydrochloric acid, hydrobromic acid, sulfuric acid, methane sulfonic acid, para-toluene sulfonic acid, phosphoric acid. And/or a with an alkaline metal halides selected from a group comprising sodium chloride, potassium chloride, lithium chloride, sodium bromide, potassium bromide, lithium bromide,
In addition, the present invention is related to the method of preparing of a compound of formula
Z1, Z2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; p is 0-4 comprising reaction of a compound of formula (IV)
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 with a compound of formula A
(A,
Z1, Z2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; in the presence of a base and a phase transfer catalyst.
The present invention is also related to the method of preparing of a compound of formula (II) or its salts thereof
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z is optionally halogen substituted C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; p is 0-4 comprising heating of a compound of formula (III) or its salts thereof
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z1, Z2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; p is 0-4 at 60-180°C under pressure of 1-32 bars.
The present invention further provides a process of preparing of a compound of formula (V) or its salts thereof
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z is, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; p is 0-4 comprising reaction of compound of a formula (I)
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z is, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; p is 0-4 with hydrogen in the presence of metal catalyst, optionally in the presence of acid.
Another aspect of the present invention is related to the method of preparing a compound of formula (VI) or its salts thereof
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 comprising a) preparing a compound of formula (V) according to above methods and b) further reaction of resulting a compound of formula (V) with an acid, optionally in the presence of organic solvent.
The present invention, additionally provides a method of preparing of a compound of formula (VIII)
wherein
X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Y is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 q is 0-5 comprising reaction of a compound of formula (VI) prepared according to the above method with a compound of formula (VII)
wherein q is an integer equal to 1, 2, 3 or 4,
Y is halogen and
L is a leaving group selected from C1-C6 alkoxy, OH, halogens, hydrogen, OSfO^R wherein R is - CH3, -C6H5-CH3; q is 0-5 in the presence of organic solvent, optionally in the presence of base.
The present invention is further related to the method of preparing of a compound of formula (VIII)
wherein
X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Y is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 q is 0-5 using the compound of formula (I)
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z is, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -CeHs-CHs; p is 0-4
Another aspect of the present invention is related to a compound of formula (XI),
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z1, Z2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; p is 0-4 and more specifically to a compound of formula (Xia),
The present invention further provides a method for preparing a compound of formula (XI),
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z1, Z2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; p is 0-4 comprising reaction of a compound of formula (IX)
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 with a compound of formula (X)
wherein Z1, Z2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3;
in the presence of organic solvent, optionally in the presence of base and optionally in the presence of phase transfer catalyst.
In addition, the present invention provides the method for the preparing a compound of formula (VI), or its salts thereof
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 comprising preparing a compound of formula (XI) according to above method with an acid, optionally in the presence of organic solvent.
Another aspect of the present invention is related to the method of preparing a compound of formula (VIII)
wherein
X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Y is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 q is 0-5 comprising reaction of a compound of formula (VI) prepared according to the above method with a compound of formula (VII)
wherein q is an integer equal to 1, 2, 3 or 4,
Y is halogen and
L is a leaving group selected from C1-C6 alkoxy, OH, halogens, hydrogen, OSfO^R; wherein R is - CH3, -C6H5-CH3;
q is 0-5
In the presence of organic solvent, optionally in the presence of base.
Specifically, the present invention is correlated to the method of preparing of a compound of formula (VIII)
wherein
X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Y is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 q is 0-5 using the compound of formula (XI)
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl; wherein Z1, Z2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO R; wherein R is -CH3, -C6H5-CH3; p is 0-4
Description of the invention:
Definitions:
Prior to setting forth the present subject matter in detail, it may be helpful to provide definitions of certain terms to be used herein. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as is commonly understood by one of skill in the art to which this subject matter pertains.
Throughout the application, descriptions of various embodiments use the term "comprising"; however, it will be understood by one skilled in the art, that in some specific instances, an
embodiment can alternatively be described using the language "consisting essentially of" or "consisting of".
The term "a" or "an" as used herein includes the singular and the plural, unless specifically stated otherwise. Therefore, the terms "a," "an" or "at least one" can be used interchangeably in this application.
The term "halogen" or "halo" as used herein refers to one or more halogen atoms, defined as F, Cl, Br, and I. Unless indicated to the contrary, the numerical parameters set forth in the following specification and attached claims are approximations that may vary depending upon the desired properties sought to be obtained. For purposes of better understanding the present teachings and in no way limiting the scope of the teachings, unless otherwise indicated, all numbers expressing quantities, percentages, or proportions, and other numerical values used in the specification and claims, are to be understood as being modified in all instances by the term "about."
At the very least, each numerical parameter should at least be construed in light of the number of reported significant digits and by applying ordinary rounding techniques. In an embodiment, use of the term "about" herein specifically includes ±10% from the indicated values in the range. In addition, the endpoints of all ranges directed to the same component or property herein are inclusive of the endpoints, are independently combinable, and include all intermediate points and ranges.
The term "carbonyl" as used herein refers to the group -C=O
The term "alkoxy," as used herein, refers to optionally substituted alkyl group attached to the parent molecular moiety through an oxygen atom.
The term "aryloxy" refers to optionally substituted aryl group attached to the parent molecular moiety through an oxygen atom.
The term "alkoxycarbonyl," as used herein, refers to optionally substituted alkoxy group attached to the parent molecular moiety through a carbonyl group.
The term "benzyloxy", as used herein, refers to a benzyl group C6H5CH2- attached to the parent molecular moiety through an oxygen atom.
The term "alkyl," as used herein, refers to a group derived from a straight or branched chain saturated hydrocarbon containing from one to six carbon atoms.
The term "telescopic process" as used herein refers to carrying out several reactions without isolating the intermediate products. In particular, the telescopic process suggests the execution of multiple transformations (including reaction quenches and other workup operations) without the direct isolation of intermediates. Telescoped solutions of intermediates can be extracted, filtered (as long as the desired product remains in the filtrate), and solvent exchanged, but the intermediate is ultimately held in solution and carried forward to the subsequent transformation.
The term "salts", as used herein, refers to organic salts such as chloride, bromide, fluoride, iodide, acetate, hydrogen sulfates, phosphates, formats, nitrate, carbonate etc., or, if applicable, alkaline metal salts such as sodium, potassium, calcium, lithium, cesium, magnesium, barium and the like.
The term "E/Z isomer", as used herein, refers to chemical compound that have the same chemical formulas, yet are different from one another, geometrically.
The present invention relates to a new compound of general formula (I):
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z is, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO R; wherein R is -CH3, -C6H5-CH3; p is 0-4
The compound of formula (I) according to the invention can exist in both E/Z form and in any mixture thereof.
The compound of formula (la) according to the invention can exist in both E/Z form and in any mixture thereof
In another embodiment, the present invention provides a method for preparing a compound of formula (I)
by reaction of a compound of formula (II) or its salts thereof
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z is, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO R; wherein R is -CH3, -C6H5-CH3; p is 0-4 with nitrite salt, optionally in the presence of solvent, optionally in the presence of an acid, optionally in the presence of phase transfer catalyst.
According to an embodiment, nitrite salt can be selected from the group comprising sodium nitrite, potassium nitrite, calcium nitrite, lithium nitrite, ammonium nitrite and the mixture thereof, preferably sodium nitrite.
According to an embodiment, a molar ratio between compound (II) to nitrite salt can be from about 1:10 to 10:1, preferably from about 1:1 to 1:5, most preferably from 1:1 to 1:1.5.
According to an embodiment the organic solvent is selected from the group consisting of aliphatic hydrocarbons (acyclic and cyclic), such as octane, heptane, hexane, pentane, cyclooctane, cyclopentane, petroleum ether, cyclohexane, cyclopentane, chlorinated hydrocarbons such as, carbon tetrachloride, chloroform, 1,2-dichloroethane, methylene chloride, optionally substituted aromatic hydrocarbons such as toluene, benzene, xylene, ethylbenzene, chlorobenzene, dichlorobenzene, trichlorobenzene, ethers (acyclic and cyclic) such as, diethyl ether, diglyme (diethylene glycol dimethyl ether), 1,4-dioxane, methyl t-butyl ether (MTBE), tetrahydrofuran (THF), methyltetrahydrofuran (Me-THF), cyclopentylmethyl ether, methyl-tert- butyl ether), aliphatic and aromatic esters, such as ethyl acetate , nitriles, such as acetonitrile, benzonitrile, ketones, such as acetone, 2-butanone , alcohols, such as methanol, ethanol, 1-butanol, 2-butanol, 1-propanol, 2-propanol t-butyl alcohol, diethylene glycol, glycerin, ethylene glycol polar aprotic solvents like dimethylformamide, dimethylacetamide, dimethyl sulfoxide, N-methyl pyrrolidone, water and the mixture thereof.
According to an embodiment, a molar ratio between compound (II) to organic solvent can be from about 1:20 to 10:1, preferably from 1:0.5 to 1:5, most preferably from about 1:3 to 1:5.
According to an embodiment the acid is selected from the group consisting of organic acid, Cl- C6 carboxylic acid, acetic acid, propionic acid, formic acid, benzoic acid, citric acid, glutamic acid, malonic acid, tartaric acid, phthalic acid, barbituric acid, cinnamic acid, glutaric acid, hexanoic acid, malic acid, folic acid, trifluoroacetic acid, ascorbic acid, glutamic acid, benzylic acid, lactic
acid, para-toluene sulfonic acid, inorganic acid, such as sulfuric acid, nitric acid, phosphoric acid, carbonic acid, hydrochloric acid, hydrobromic acid, nitric acid, and the mixture thereof.
According to an embodiment, a molar ratio between compound (II) to acid can be from about 1:20 to 10:1, preferably from about 1:1 to 1:5, most preferably from about 1:3 to 1:5.
According to an embodiment the phase transfer catalyst selected from the group consisting of ammonium salt or polyethers selected from the group consisting of pyridinium hydrochloride, pyridinium acetate, pyridinium triflate, pyridinium hydrobromide, tetrabutylammonium bromide, tetrabutylammonium chloride, tetrabutylammonium fluoride, tetrabutylammonium hydrogen sulfate, tetrabutylammonium iodide, tetraethylammonium bromide, tetraethylammonium chloride, tetraethylammonium hydrogen sulfate, tetraethylammonium iodide, tetramethylammonium bromide, tetramethylammonium chloride, tetramethylammonium hydrogen sulfate, tetramethylammonium iodide, tetrapropylammonium bromide, tetrapropylammonium chloride, tetrapropylammonium hydrogen sulfate, tetrapropylammonium iodide, tetraoctylammonium bromide, tetraoctylammonium chloride, tetraoctylammonium hydrogen sulfate, tetraoctylammonium iodide, crown ethers, polyethylene glycol, and the mixtures thereof, preferably, tetrabutylammonium bromide.
According to an embodiment, a molar ratio between compound (II) to phase transfer catalyst can be from about 1:1 to 1:0.0001, preferably from about 1:0.01 to 1:0.1, most preferably from about 1:0.05 to 1:0.01.
According to an embodiment, the compound of formula (II) contacted with the nitrite salt at the temperature interval of from 10 to 130°C. A preferred temperature interval is from 15 to 50°C., more preferably from 15 to 25°C.
According to an embodiment, the nitrite salt can be added to the mixture of compound (II), as a solid or as an aqueous solution. In case of that the nitrite salt is added as an aqueous solution to the compound (II) mixture, a weight ratio between the aqueous solution and the compound (II) mixture, can be of from 10:1 and 1:10 w/w, preferably from 0.5:1 to 2:1, most preferably a 1:1 w/w.
According to an embodiment the reaction mixture is allowed to stir between 1 minute to 10 hours according to the reaction progress, preferably from 1 to 2 hours. According to an embodiment the reaction temperature interval is from 0 to 130°C, preferably from 0 to 50°C, most preferably from 10 to 20°C.
According to an embodiment the reaction mixture is monitored by HPLC analytical method, and the process ends when concentration of formula (II) is between 0-99%, preferably from 0-50%, most preferably, in particular, when no more than 1% of compound of formula (II) remains in the reaction media.
Finally, the reaction mixture containing the resulting a compound of formula (I) is worked up. This stage may include adding water, adding organic solvent, stirring, cooling, heating, phases
separation, distillation, precipitation, recrystallization, concentration, filtration, purification, pH adjustment, extraction, and drying processes.
In another embodiment, the present invention provides a method of preparing a compound of formula (II) or its salts thereof,
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z is, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; p is 0-4 by two-step reaction, which can be performed as separated processes or as combined processes, such as one-pot reaction, telescopic-reaction, preferably, in one-pot reaction process. The intermediates formed in the above process can be isolated from the reaction mixture or the process can be continued without isolation of said intermediates.
According to the embodiment the first step provides the method of preparing a compound of formula (III), or its salts thereof,
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z1, Z2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3;; p is 0-4 by reaction of a compound of formula (IV)
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
p is 0-4 with compound of formula A
O O
Z1^^Z2 (A)
Z1, Z2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO R; wherein R is -CH3, -C6H5-CH3;; in the presence of base, organic solvent, and phase transfer catalyst
According to an embodiment the compound (A) is selected from the group consisting of methyl malonate, ethyl malonate, propyl malonate, hexyl malonate, cyclohexyl malonate, benzyl malonate, chloromethyl malonate, chloroethyl malonate, chloropropyl malonate, chlorohexyl malonate, chlorocyclohexyl malonate, chlororbenzyl malonate, bromomethyl malonate, bromoethyl malonate, bromopropyl malonate, bromohexyl malonate, bromocyclohexyl malonate, bromorbenzyl malonate, malonic acid and the mixtures thereof, preferably, methyl malonate or ethyl malonate.
According to an embodiment, a molar ratio between compound (IV) to malonic acid or alkyl malonate can be from about 1:10 to 10:1, preferably from 2:1 to 1:2, most preferably from about 1:1 to 1:1.5
According to an embodiment the base is selected from the group consisting of aluminum hydroxide, calcium hydroxide, calcium hydroxide, iron(ll) hydroxide, lithium hydroxide, potassium hydroxide, ammonium hydroxide, sodium hydroxide, sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate, calcium carbonate, trimethylamine, tributylamine, diisopropylamine, tetrmethylethylendiamine, pyridine, dimethylbenzylamine, quinoline, aniline, imidazole, pyrrole, pyrrolidine, pyrimidine, piperidine, piperazine, morpholine, N-methyl morpholine, N-ethyl pyrrolidine, diisopropylmehtylamine, diisopropylethylamine, triallyl amine, diallyl amine, indole, butyl lithium, sodium hydride, potassium hydride, and the mixtures thereof, preferably, potassium bicarbonate.
According to an embodiment, the molar ratio between compound (IV) to the base can be from about 1:10 to 10:1, preferably from 2:1 to 1:5, most preferably from about 1:1 to 1:3.
According to an embodiment the organic solvent is selected from the group consisting of aliphatic hydrocarbons (acyclic and cyclic) such as, octane, heptane, hexane, pentane, cyclooctane, cyclopentane, petroleum ether, cyclohexane, cyclopentane, chlorinated hydrocarbons such as, carbon tetrachloride, chloroform, 1,2-dichloroethane, methylene chloride, aromatic hydrocarbons with or without substitution such as, toluene, benzene, xylene, ethylbenzene, chlorobenzene, dichlorobenzene, trichlorobenzene), all ethers (acyclic and cyclic) such as, diethyl ether, diglyme (diethylene glycol dimethyl ether), 1,4-dioxane, methyl t-butyl ether (MTBE), tetrahydrofuran (THF), methyl-
tetrahydrofuran (Me-THF), cyclopentylmethyl ether, methyl-tert- butyl ether), all aliphatic and aromatic esters such as, ethyl acetate , nitriles such as, acetonitrile, benzonitrile, ketones such as, acetone, 2-butanone , alcohols such as, methanol, ethanol, 1-butanol, 2-butanol, 1-propanol, 2-propanol t-butyl alcohol, diethylene glycol, glycerin, ethylene glycol, polar aprotic solvents like dimethylformamide, dimethylacetamide, dimethyl sulfoxide, N-methyl pyrrolidone, water and the mixture thereof, preferably, a mixture of dimethyl sulfoxide and toluene.
According to an embodiment, a w/w ratio between compound (IV) to organic solvent can be from about 1:20 to 20:1, preferably from about 1:1 to 1:10, most preferably from about 1:3 to 1:5.
According to an embodiment the phase transfer catalyst selected from the group consisting of ammonium salt or polyethers selected from the group consisting of pyridinium hydrochloride, pyridinium acetate, pyridinium triflate, pyridinium hydrobromide, tetrabutylammonium bromide, tetrabutylammonium chloride, tetrabutylammonium fluoride, tetrabutylammonium hydrogen sulfate, tetrabutylammonium iodide, tetraethylammonium bromide, tetraethylammonium chloride, tetraethylammonium hydrogen sulfate, tetraethylammonium iodide, tetramethylammonium bromide, tetramethylammonium chloride, tetramethylammonium hydrogen sulfate, tetramethylammonium iodide, tetrapropylammonium bromide, tetrapropylammonium chloride, tetrapropylammonium hydrogen sulfate, tetrapropylammonium iodide, tetraoctylammonium bromide, tetraoctylammonium chloride, tetraoctylammonium hydrogen sulfate, tetraoctylammonium iodide, crown ethers, polyethylene glycol, and the mixtures thereof, preferably, tetrabutylammonium bromide.
According to an embodiment, a molar ratio between compound (IV) to phase transfer catalyst can be from about 1:1 to 1:0.0001, preferably from about 1:0.1 to 1:0.001, most preferably from about 1:0.05 to 1:0.01
According to an embodiment, compound (III) is produced by mixing of a compound of formula (IV), malonic acid or malonate derivative, and base in organic solvent, and heating the mixture to temperature interval from 20 to 130°C, preferably from 50 to 110°C, most preferably from 80 to 100°C.
According to an embodiment the reaction mixture is allowed to stir between 1 to 10 hours according to the reaction progress, preferably from to 10 hours, most preferably from 5 to 7 hours.
According to an embodiment the reaction mixture is monitored by HPLC analytical method and ends when concentration of formula (IV) is between 0-99%, preferably from 0-50%, most preferably, in particular, when no more than 1% of compound of formula (IV) remains in the reaction media.
Finally, the reaction mixture containing the resulting a compound of formula (III) is worked up. This stage may include, cooling, adding water, adding organic solvent, stirring, cooling, heating,
phases separation, distillation, precipitation, recrystallization, concentration, filtration, washing, purification, pH adjustment, extraction, and drying processes.
According to the embodiment a second step, which is completed as in one-pot process, comprising the method of preparing a compound of formula (II) or its salts thereof,
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z is, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO R; wherein R is -CH3, -C6H5-CH3; p is 0-4
According to the embodiment a compound of formula (II) is prepared by the process provide the reaction of a compound of formula (III) or its salts thereof
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl,
Z1, Z2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfOhR; wherein R is -CH3, -C6H5-CH3; p is 0-4 in the presence of an acid, and/or, with an alkaline metal halides
According to an embodiment the acid in the above process is selected from the group consisting of sulfuric acid, nitric acid, phosphoric acid, carbonic acid, hydrochloric acid, hydrobromic acid, nitric acid, and the mixture thereof, preferably, hydrochloric acid.
According to an embodiment, a w/w ratio between compound (III) to the acid can be from about 1:0.5 to 1:10, preferably from 1:0.5 to 1:5, most preferably from about 1:1 to 1:2
According to an embodiment the alkaline metal halides is selected from a group consisting of sodium chloride, potassium chloride, lithium chloride, sodium bromide, potassium bromide, lithium bromide, most preferably sodium chloride or potassium chloride
According to an embodiment, a w/w ratio between compound (III) to the alkaline metal halides can be from about 1:0.1 to 1:10, preferably from 1:0.5 to 1:5, most preferably from about 1:1.5 to 1:2.5
According to an embodiment, compound (II) is produced by mixing of a compound of formula (III), and acid, and heating the mixture to temperature interval from 20 to 130°C, preferably from 100 to 130°C, most preferably from 120 to 130°C.
According to an embodiment the reaction mixture is allowed to stir between 1 to 10 hours according to the reaction progress, preferably from 5 to 10 hours, most preferably from 8 to 9 hours.
According to an embodiment the reaction mixture is monitored by HPLC analytical method and ends when concentration of formula (III) is between 0-99%, preferably from 0-50%, in particular, when no more than 2.5% of compound of formula (III) remains in the reaction media.
Finally, the reaction mixture containing the resulting a compound of formula (II) is worked up. This stage may include cooling, adding water, adding organic solvent, stirring, heating, phase separation, distillation, precipitation, recrystallization, concentration, filtration, decantation, washing, purification, pH adjustment, extraction, and drying processes.
According to alternative embodiment of a method of preparing a compound of formula (II) or its salts thereof,
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z is, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO R; wherein R is -CH3, -C6H5-CH3; p is 0-4 comprising heating of a compound of formula (III) or its salts thereof
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z1, Z2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; p is 0-4 at high temperature of between 60 to 200°C, preferably from 120 to 180°C, most preferably from 140 to 160°C, and under pressure of between 1 to 32 bars, preferably from 15-25 bars, most preferably from 19-23 bars.
According to an embodiment the reaction mixture is monitored by HPLC analytical method and ends when concentration of formula (III) is between 0-99%, preferably from 0-50%, in particular, when no more than 1% of compound of formula (III) remains in the reaction media.
In another embodiment, of this present invention, a method of preparing a compound of formula (VI), or its salts thereof
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 via two steps reaction which can be performed as separate processes or as combine process, such as one-pot reaction, telescopic-reaction, preferably, in one-pot reaction process, is described.
According to the embodiment, the first step provides the method of preparing a compound of formula (V) or its salts thereof,
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z is, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; p is 0-4 comprising reaction of a compound of formula (I)
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z is, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; p is 0-4 with hydrogen in the presence of metal catalyst, optionally in the presence of acid.
According to an embodiment, the metal catalyst is selected form the group comprising zinc, iridium, nickel, palladium, platinum, rhodium, or ruthenium, cobalt, tin, iron, Raney Ni, or metal salts selected form the group of iron chlorides, iron nitrates, nickel chlorides, nickel bromides, Grubs catalysts, and the mixtures thereof.
According to an embodiment, a w/w ratio between compound (I) to catalyst can be from about 1:1 to 1:0.0001, preferably from 1:0.005 to 1:0.5, most preferably from about 1:0.05 to 1:0.15
According to an embodiment, optionally in the presence of C1-C4 carboxylic acid selected form the group comprising acetic acid, propionic acid, butyric acid, lactic acid, formic acid, citric acid, oxalic acid, malic acid, tartaric acid, and a mixture thereof, preferably, acetic acid.
According to an embodiment, a w/w ratio between compound (I) to C1-C4 carboxylic acid can be from about 1:10 to 1:0.5, preferably from 1:10 to 1:1, most preferably from about 1:8 to 1:2
According to an embodiment, optionally in the presence of hydrogen gas at a pressure of between 4-20bar, preferably from 8 to 16 bar, most preferably from about 10-15 bar.
According to an embodiment, compound (V) is produced by mixing of a compound of formula (I), and optionally acid, and optionally hydrogen gas and at temperature interval of from 20 to 130°C, preferably from 50 to 100°C, most preferably from 70 to 80°C.
According to an embodiment, the reaction mixture is allowed to stir between 1 to 10 hours according to the reaction progress, preferably from 5 to 10 hours, most preferably from 5 to 8 hours.
According to an embodiment, the reaction mixture is monitored by HPLC analytical method and ends when concentration of formula (I) is between 0-99%, preferably from 0-50%, in particular, when no more than 1% of compound of formula (I) remains in the reaction media.
Finally, the reaction mixture containing the resulting a compound of formula (V) is worked up. This stage may include, cooling, adding water, adding organic solvent, stirring, heating, phases
separation, distillation, precipitation, recrystallization, concentration, filtration, washing, purification, pH adjustment, extraction, and drying processes.
According to the embodiment, the second step comprising the method of preparing a compound of formula (VI), or its salts thereof
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 comprising reaction of a compound of formula (V)
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z is, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO R; wherein R is -CH3, -C6H5-CH3; p is 0-4 in the presence of an acid, optionally in the presence of organic solvent.
According to an embodiment the acid is selected from the group consisting of sulfuric acid, nitric acid, phosphoric acid, carbonic acid, hydrochloric acid, hydrobromic acid, nitric acid, and the mixture thereof, preferably, hydrochloric acid.
According to an embodiment, molar ratio between compound (V) to acid can be from about 1:10 to 1:0.5, preferably, from about 1:2 to 1:4.
According to an embodiment the organic solvent is selected from water, dichloromethane, methanol, ethanol, isopropanol, tert-butanol, dimethylformamide, 1,4- dioxane, ethyl acetate, acetonitrile, tetrahydrofuran, acetic acid, toluene, benzene, hexane, cyclohexane, dimethyl sulfoxide, pyridine, diethyl ether, chloroform, 1,2-dichloroethane, acetone, isopropyl acetate, anisole, A/-methyl-2-pyrrolidone, 4-methylmorpholine, nitromethane and the mixtures thereof, preferably, toluene.
According to an embodiment, a w/w ratio between compound (V) to organic solvent can be from about 1:10 to 10:1, preferably from 1:1 to 1:5, most preferably from about 1:2 to 1:4.
According to an embodiment, compound (VI) is produced by mixing of a compound of formula (V), acid, and organic solvent, and heating the resulting mixture to temperature of from 20 to 130°C, preferably from 50 to 100°C, most preferably from 60 to 70°C.
According to an embodiment the reaction mixture is allowed to stir between 10 minutes to 5 hours according to the reaction progress, preferably from 0.5 to 3 hours, most preferably from 1 to 2 hours.
According to an embodiment the reaction mixture is monitored by HPLC analytical method, and the reaction ends when concentration of formula (V) is 0-99%, preferably 0-50%, in particular, when no more than 2.5% of compound of formula (V) remains in the reaction media.
Finally, the reaction mixture containing the resulting a compound of formula (VI) is worked up. This stage may include, cooling, adding water, adding organic solvent, stirring, heating, phases separation, distillation, precipitation, recrystallization, concentration, filtration, washing, purification, pH adjustment, extraction, and drying processes.
According to another embodiment, the compound of formula (VIII), which is a well-known fungicide compound of the fluopicolide of formula:
wherein
X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Y is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 q is 0-5 is prepared by a process provides the steps of a) preparation of compound (VI) as described above via compound of formula (I), b) reaction of compound (VI) with compound of formula (VII) in the presence of organic solvent, optionally in the presence of base.
wherein q is an integer equal to 1, 2, 3 or 4,
Y is halogen and
L is a leaving group selected from C1-C6 alkoxy, OH, halogens, halide, OSfOhR; wherein R is -CH3, -C6H5-CH3; q is 0-5
According to an embodiment, the base is selected from the group comprising of alkali and alkaline earth metal hydroxides, alkoxides, carbonates and bicarbonates and organic primary, secondary and tertiary amines, such as triethylamine, diisopropylethylamine, pyridine, potassium carbonate, potassium bicarbonate, sodium carbonate, sodium bicarbonate, sodium hydroxide, aniline, chloroaniline and the mixture thereof, preferably sodium hydroxide.
According to an embodiment, molar ratio between compound (VI) to base can be from about 1:10 to 1:0.5, preferably 1:1 to 1:5, most preferably from about 1:2 to 1:3
According to an embodiment, the organic solvent selected from the group comprising aliphatic cyclic and acyclic hydrocarbons, halogenated aliphatic cyclic and acyclic hydrocarbons, aromatic hydrocarbons, halogenated aromatic hydrocarbons, ethers, aliphatic and aromatic esters, nitriles, ketones, C1-C4 alcohols, n-alkyls protic and aprotic polar solvents such as, dichloromethane, chloroform, pyridine, tetrahydrofuran, dimethylformamide, ethyl acetate, toluene, 1,4-dioxane, diethyl ether, isopropyl acetate, methanol, ethanol, acetonitrile, pyrrolidones, dimethylformamide, dimethylacetamide, dimethyl sulfoxide, water and the mixtures thereof, preferably toluene.
According to an embodiment, w/w ratio between compound (VI) to solvent can be from about 1:1 to 1:20, preferably 1:1 to 1:5, most preferably from about 1:2 to 1:3
According to an embodiment, base can be added as solid or as an aqueous solution of between 1% to 60% w/w, preferably as aqueous solution of about 2 to 20% w/w, most preferably 5 to 10% w/w.
According to an embodiment, w/w ratio between compound (VI) to aqueous base solution can be from about 1:001 to 1:1, preferably from about 1:0.01 to 1:0.5, most preferably from about 1:0.05 to 1:0.15.
According to an embodiment, the compound of formula (VII) preferably contacted with the compound of formula (VI), at raised temperature. A preferred temperature interval is from 0 to 130°C, preferably from 0 to 50°C, most preferably from 10 to 20°C.
According to an embodiment the reaction mixture is allowed to stir for 1 minute to 10 hours after completion of the addition, preferably for 10 minutes to 5 hours, most preferably for 1 to 2 hours.
According to an embodiment the reaction temperature interval of the stirring phase is from 0 to 130°C, preferably from 10 to 50°C, most preferably from 20 to 30°C.
According to an embodiment the reaction mixture is monitored by HPLC analytical method and ends when concentration of formula (VI) is between 0-99%, preferably from 0-50%, in particular, when no more than 0.5% of compound of formula (VI) remains in the reaction media.
Finally, the reaction mixture containing the resulting a compound of formula (VIII) is worked up. This stage may include adding water, adding organic solvent, stirring, cooling, heating, phases separation, distillation, precipitation, recrystallization, concentration, filtration, purification, pH adjustment, extraction, and drying processes.
In additional embodiment, the present invention relates to a new derivative of general formula (XI)
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z1, Z2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; p is 0-4 and more specifically to a compound of formula (Xia),
According to an embodiment, the present invention provides a method of preparing a compound of formula (VI) or its salts thereof,
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4
via two steps reaction which can be performed as separate processes or as combined process, such as one-pot reaction, telescopic-reaction, preferably, in one-pot reaction process, is displayed.
According to an embodiment, the first step comprising the method of preparing of a compound of formula (XI)
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z1, Z2 are independently, optionally halogen substituted C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; p is 0-4 by reaction of a compound of formula (IV)
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 with a compound of formula (X)
Z1, Z2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO R; wherein R is -CH3, -C6H5-CH3; in the presence of organic solvent, optionally in the presence of base, and optionally in the presence of phase transfer catalyst.
According to an embodiment, a molar ratio between compound (IV) to compound (X) can be from about 1:10 to 10:1, preferably 1:0.5 to 1:5, most preferably from about 1:1 to 1:2.
According to an embodiment, base is selected from the group comprising of triethylamine, diisopropylethylamine, pyridine, potassium carbonate, potassium bicarbonate, sodium
carbonate, sodium bicarbonate, sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium alkoxide, potassium alkoxide, potassium tert-butoxide, sodium hydride, potassium hydride, butyl lithium, lithium diisopropyl amine, aniline, p-chloroaniline and the mixtures thereof, preferably potassium carbonate.
According to an embodiment, a molar ratio between compound (IV) to the base can be from about 1:5 to 0.5:1.0, preferably from about 1:1 to 1:5, most preferably from about 1:1.5 to 1:2.5.
According to an embodiment, organic solvent selected from dichloromethane, chloroform, pyridine, water, tetrahydrofuran, dimethyl sulfoxide, N-methyl pyrrolidone, dimethylformamide, ethyl acetate, toluene, 1,4-dioxane, diethyl ether, isopropyl acetate, methanol, ethanol, acetonitrile, dimethylacetamide and the mixtures thereof, preferably dimethyl sulfoxide.
According to an embodiment, a w/w ratio between compound (IV) to solvent can be from about 1:20 to 1:0.1, preferably from about 1:1 to 1:10, most preferably from about 1:3 to 1:5.
According to an embodiment, phase transfer catalyst selected from the group comprising of quaternary ammonium salts, phosphonium salts, polyether's and the mixtures thereof, such as benzyltriethylammonium chloride, methyltricaprylammonium chloride, methyltributylammonium chloride, and methyltrioctylammonium chloride, tetra-n- butylammoniumchloride, tetra-n-butylammonium bromide tetra-n-butylammonium iodide tetra-n-butylammonium fluoride, crown ethers, polyethylene glycols and the mixture thereof, preferably, tetra-n-butylammonium bromide.
According to an embodiment, a molar ratio between compound (IV) to phase transfer catalyst can be from about 1:1 to 1:0.0001, preferably 1:0.25 to 1:0.025, most preferably from about 1:0.15 to 1:0.05
According to an embodiment, the second step provides the method of preparing of a compound of formula (VI) or its salts thereof,
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 comprising reaction of a compound of formula (XI)
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z1, Z2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; p is 0-4 in the presence of acid optionally in the presence of organic solvent.
According to an embodiment the acid is selected from the group consisting of sulfuric acid, nitric acid, phosphoric acid, carbonic acid, hydrochloric acid, hydrobromic acid, nitric acid, and the mixture thereof, preferably, hydrochloric acid.
According to an embodiment, molar ratio between compound (XI) to the acid can be from about 1:10 to 1:0.5, preferably from about 1:1 to 1:10, mot preferably from about 1:4 to 1:6.
According to an embodiment the organic solvent is selected organic solvent selected from water, dichloromethane, methanol, ethanol, isopropanol, tert-butanol, dimethylformamide, 1,4- dioxane, ethyl acetate, acetonitrile, tetrahydrofuran, acetic acid, toluene, benzene, hexane, cyclohexane, dimethyl sulfoxide, pyridine, diethyl ether, chloroform, 1,2-dichloroethane, acetone, isopropyl acetate, anisole, A/-methyl-2-pyrrolidone, 4-methylmorpholine, nitromethane and the mixtures thereof, preferably, toluene.
According to an embodiment, a w/w ratio between compound (XI) to the organic solvent can be from about 1:10 to 10:0.1, preferably from ,1:10 to 1:1, most preferably from about 1:5 to 1:1.
According to an embodiment, compound (VI) is produced by mixing of a compound of formula (XI), acid, and organic solvent, and heating the mixture to temperature interval from 0 to 130°C, preferably from 50 to 120°C, most preferably from 100 to 115°C.
According to an embodiment, the reaction mixture is allowed to stir between 10 minutes to 20 hours according to the reaction progress, preferably from 5 to 15 hours, most preferably from 12 to 15 hours.
According to an embodiment, the reaction mixture is monitored by HPLC analytical method and ends when concentration of formula (XI) is 0-99%, preferably 0-50%, in particular, when no more than 2.0% of compound of formula (XI) remains in the reaction media.
Finally, the reaction mixture containing the resulting compound of formula (XI) is worked up. This stage may include, cooling, adding water, adding organic solvent, stirring, heating, phases separation, distillation, precipitation, recrystallization, concentration, filtration, washing, purification, pH adjustment, extraction, and drying processes.
X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Y is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 q is 0-5 is prepared by a process comprising the steps of: a) preparation of compound (VI) as described above via compound of formula (XI) b) reaction of compound (VI) with compound of formula (VII) in the presence of organic solvent, optionally in the presence of base.
wherein q is an integer equal to 1, 2, 3 or 4,
Y is halogen and
L is a leaving group selected from C1-C6 alkoxy, OH, halogens, halide, OSfO^R; wherein R is -CH3, -C6H5-CH3; q is 0-5
According to an embodiment, the base is selected from the group comprising of alkali and alkaline earth metal hydroxides, alkoxides, carbonates and bicarbonates and organic primary, secondary and tertiary amines, such as triethylamine, diisopropylethylamine, pyridine, potassium carbonate, potassium bicarbonate, sodium carbonate, sodium bicarbonate, sodium hydroxide, aniline, chloroaniline and the mixture thereof, preferably sodium hydroxide.
According to an embodiment, molar ratio between compound (VI) to base can be from about 1:10 to 1:0.5, preferably 1:1 to 1:5, most preferably from about 1:2 to 1:3
According to an embodiment, the organic solvent selected from the group comprising aliphatic cyclic and acyclic hydrocarbons, halogenated aliphatic cyclic and acyclic hydrocarbons, aromatic hydrocarbons, halogenated aromatic hydrocarbons, ethers, aliphatic and aromatic esters, nitriles, ketones, C1-C4 alcohols, n-alkyls protic and aprotic polar solvents such as, dichloromethane, chloroform, pyridine, tetrahydrofuran, dimethylformamide, ethyl acetate, toluene, 1,4-dioxane, diethyl ether, isopropyl acetate, methanol, ethanol, acetonitrile,
pyrrolidones, dimethylformamide, dimethylacetamide, dimethyl sulfoxide, water and the mixtures thereof, preferably toluene.
According to an embodiment, w/w ratio between compound (VI) to solvent can be from about 1:1 to 1:20, preferably 1:1 to 1:5, most preferably from about 1:2 to 1:3
According to an embodiment, base can be added as solid or as an aqueous solution of from 1% to 60% w/w, preferably as aqueous solution of from 2 to 20% w/w, most preferably from 5 to 10% w/w.
According to an embodiment, w/w ratio between compound (VI) to aqueous base solution can be from about 1:001 to 1:1, preferably from about 1:0.01 to 1:0.5, most preferably from about 1:0.05 to 1:0.15.
According to an embodiment, the compound of formula (VII) preferably contacted with the compound of formula (VI), at raised temperature. A preferred temperature interval is from 0 to 130°C, preferably from 0 to 50°C, most preferably from 10 to 20°C.
According to an embodiment the reaction mixture is allowed to stir for 1 minute to 10 hours after completion of the addition, preferably for 10 minutes to 5 hours, most preferably for 1 to 2 hours.
According to an embodiment the reaction temperature interval of the stirring phase is from 0 to 130°C, preferably from 10 to 50°C, most preferably from 20 to 30°C.
According to an embodiment the reaction mixture is monitored by HPLC analytical method and ends when concentration of formula (VI) is between 0-99%, preferably from 0-50%, in particular, when no more than 0.5% of compound of formula (VI) remains in the reaction media.
Finally, the reaction mixture containing the resulting a compound of formula (VIII) is worked up. This stage may include adding water, adding organic solvent, stirring, cooling, heating, phases separation, distillation, precipitation, recrystallization, concentration, filtration, purification, pH adjustment, extraction, and drying processes.
EXAMPLES:
Example 1: Preparation of Methyl 2-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)acetate (compound II) from 2,3-Dichloro-5-(trifluoromethyl)pyridine (compound IV) via Dimethyl-2-(3-chloro-5- (trifluoromethyl)pyridine-2-yl)malonate (compound III):
To a IL reactor equipped with dean-stark condenser, toluene (180 mL), potassium carbonate (138 gr), dimethyl aminopyridine (2.82 gr) and tetra-n-butylammonium bromide (7.46 gr) were charged at 25°C and stirred for 5 minutes. The reaction was then heated to azeotropic reflux at
115°Cfor 30 minutes through 1 hour. 3 mL of water was collected, and the heating was continued until no water collection was detected. The mixture was cooled to 85°C and dimethyl malonate (77.7 gr), and dimethyl sulfoxide (120 mL) were added dropwise, followed by dropwise addition of compound (IV) (100 gr). The mixture was heated to 100°C through 6 hours. The reaction progress was monitored by HPLC and ended when compound (IV) was less than 1.5% in the reaction mixture. The mixture was cool to 25°C and the pH was adjusted by cone. HCI (160 mL). Solid particles were filtered and washed with Toluene (200 mL) twice. Toluene was distilled out to give compound (III) in dimethyl sulfoxide. The mixture was acidified by cone. HCI to adjust the pH to 2.5. The mixture was heated to 115°C through 16 hours. The reaction progress was monitored by HPLC and ended when compound (III) was less than 1.5% in the reaction mixture. The mixture was cooled to 25°C and water (400 mL) was added followed by Toluene (200 mL). Mixture was stirred, settled and organic layer was separated. Aqueous layer was washed again with toluene (200 mL) and organic phases were combined. Toluene was distillated to give (%w/w) 109 gr oily crude product containing compound (II), 75-77% yield.
Example 2: Preparation of Dimethyl-2-(3-chloro-5-(trifluoromethyl)pyridine-2-yl)malonate (compound III) from 2,3-Dichloro-5-(trifluoromethyl)pyridine (compound IV):
To a IL reactor equipped with a condenser, N-methyl-2-pyrrolidone (300 mL), potassium carbonate (142 gr), were charged at 25°C and stirred for 5 minutes. 2,3-Dichloro-5- (trifluoromethyl)pyridine (100 gr) was charged to the reactor and mixture was stirred for 15 minutes. Dimethyl malonate (77.3 gr) was charged to the reactor and mixture was stirred for 15 minutes. The reaction was then heated to 75°C for 1 hour. Temperature was increased to 90°C for additional 9h. The reaction progress was monitored by HPLC and ended when compound (IV) was less than 1.5% in the reaction mixture. The mixture was cool to 25°C and the pH was adjusted by cone. HCI (160 mL). Solid particles were filtered and washed with N-methyl-2-pyrrolidone (200 mL) twice. N-Methyl-2-pyrrolidone was distilled out to give an oily crude product containing compound (III), 92% yield.
Example 3: Preparation of Dimethyl-2-(3-chloro-5-(trifluoromethyl)pyridine-2-yl)malonate
(compound III) from 2,3-Dichloro-5-(trifluoromethyl)pyridine (compound IV):
To a 2L reactor equipped with a condenser, toluene (700 mL), potassium carbonate (136 gr), dimethyl malonate (78.3 gr) tetra-n-butylammonium bromide (7.4 gr) and dimethyl aminopyridine (2.8 gr) were charged at 25°C and stirred for 5 minutes. 2,3-Dichloro-5- (trifluoromethyl)pyridine (103 gr) was charged to the reactor and mixture was stirred for 15 minutes. The reaction was then heated to 115°C for 14 hour. The reaction progress was monitored by HPLC and ended when compound (IV) was less than 1.5% in the reaction mixture. The mixture was cool to 25°C and the pH was adjusted by cone. HCI (160 mL). Solid particles were filtered and washed with toluene (200 mL) twice. Toluene was distilled out to give an oily crude product containing compound (III), 91% yield.
Example 4: Preparation of Dimethyl-2-(3-chloro-5-(trifluoromethyl)pyridine-2-yl)malonate (compound III) from 2,3-Dichloro-5-(trifluoromethyl)pyridine (compound IV):
To a IL reactor equipped with a condenser, N,N-di methyl acetamide (150 mL), potassium carbonate (96 gr), dimethyl malonate (77.4 gr) tetra-n-butylammonium bromide (7.4 gr) and dimethyl aminopyridine (2.8 gr) were charged at 25°C and stirred for 5 minutes. 2,3-Dichloro-5- (trifluoromethyl)pyridine (100 gr) was charged to the reactor and mixture was stirred for 15 minutes. The reaction was then heated to 90°C for 8 hours. The reaction progress was monitored by HPLC and ended when compound (IV) was less than 1.5% in the reaction mixture. The mixture was cool to 25°C and the pH was adjusted by cone. HCI (160 mL). Solid particles were filtered and washed with N,N-dimethyl acetamide (200 mL) twice. N,N-dimethyl acetamide was distilled out to give an oily crude product containing compound (III), 93% yield.
Example 5: Preparation of Dimethyl-2-(3-chloro-5-(trifluoromethyl) pyridin-2-yl)malonate (compound III) from 2,3-Dichloro-5-(trifluoromethyl)pyridine (compound IV):
To a 0.25L reactor equipped with reflux condenser, compound (IV) (25 gr), dimethyl malonate (19.4 gr), potassium carbonate (34 gr), dimethyl aminopyridine (0.7 gr) and tetra-n- butylammonium bromide (1.88 gr) were charged at 25°C and stirred for 5 minutes. The reaction was then heated to azeotropic reflux at 85°C for 3 hours. The reaction progress was monitored by HPLC and ended when compound (IV) was less than 1.5% in the reaction mixture. Viscous oily residue was obtained to give, 72% yield of compound (III).
Example 6: Preparation of Methyl-2-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)acetate (compound II) from Dimethyl-2-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)malonate (compound III):
To a 0.250L reactor equipped with reflux condenser, compound (III) (20 gr), dimethyl sulfoxide (40 mL) and 30% sodium chloride aqueous solution (25 mL) were charged at 25°C and stirred for 5 minutes. The reaction was then heated to 110°C for 24 hours. The reaction progress was monitored by HPLC and ended when compound (III) was less than 2.0% in the reaction mixture. Mixture was cool to 25°C and water (100 mL) was added. The organic compound was extracted twice with toluene (100 mL). Toluene was distilled out to give a viscous oily residue with 80% of compound (II), 94% yield of compound (II).
Example 7: Preparation of Methyl 2-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)acetate (compound II) from Dimethyl-2-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)malonate (compound III):
To a 0.250L autoclaved reactor, compound (III) (10 gr), and dimethyl sulfoxide (20 mL) were charged at 25°C and stirred for 5 minutes. The reaction was then heated to 145°C for 7 hours. The reaction progress was monitored by HPLC and ended when compound (III) was less than 1.5% in the reaction mixture. Viscous oily residue was obtained to give, 62% yield of compound (ID-
Example 8: Preparation of Methyl -2-(3-chloro-5-(trifluoromethyl) pyridine-2-yl)- (hydroxylimine)acetate (compound I) from Methyl 2-(3-chloro-5-(trifluoromethyl) pyridin-2-yl) acetate (compound II):
To a IL reactor, methyl 2-(3-chloro-5-(trifluoromethyl)pyridine-2-yl)acetate (107 gr), acetic acid (100 mL) and water (30 mL) were charged at 25°C, and stirred for 5 minutes. The mixture was cooled to 10°C and solution of sodium nitrite (35.72 gr) in water (40 mL) was added dropwise, maintaining the temperature below 25°C. The mixture was allowed to stir for 2 hours at 15°C. The reaction progress was monitored by HPLC and ended when compound (II) was less than 1.5% in the reaction mixture. Water (350 mL) was added, and mixture was cooled to 5°C. Solid was filtered, washed with water (100 mL) and dried under vacuum, to give solid compound (I), 97% yield.
Example 9: Preparation of Methyl-2-(3-chloro-5-(trifluoromethyl) pyridine-2-yl)- (hydroxylimine)acetate (compound I) from Methyl 2-(3-chloro-5-(trifluoromethyl) pyridin-2-yl) acetate (compound II):
To a IL reactor, methyl 2-(3-chloro-5-(trfluoromethyl)pyridine-2-yl)acetate (20 gr), acetic acid (100 mL), water (30 mL) and tetra-n-butylammonium bromide (2.54 gr) were charged at 25°C, and stirred for 5 minutes. The mixture was cooled to 10°C and solution of sodium nitrite (35.72 gr) in water (40 mL) was added dropwise, maintaining the temperature below 25°C. The mixture was allowed to stir for 2 hours at 15°C. The reaction progress was monitored by HPLC and ended when compound (II) was less than 1.5% in the reaction mixture. Water (350 mL) was added, and mixture was cooled to 5°C. Solid was filtered, washed with water (100 mL) and dried under vacuum, to give solid compound (I), 97% yield.
Example 10: Preparation of (3-Chloro-5-(trifluoromethyl)pyridin-2-yl)methanamine Hydrochloride (compound VI) from Methyl-2-(3-chloro-5-(trifluoromethyl)pyridine-2-yl)-(hydroxylimine)acetate (compound I) via methyl 2-amino-2-(3-chloro-5-trifluoromehtyl)pyridine-2-yl)acetate (compound V)
To a IL autoclave reactor, Methyl -2-(3-chloro-5-(trifluoromethyl)pyridine-2-yl)- (hydroxylimine)acetate (20 gr), acetic acid (200 mL) and Raney Ni (2 gr) were charged. The autoclave was closed and heated to 75°C for 8 hours. The reaction progress was monitored by HPLC and ended when compound (I) was less than 1.5% in the reaction mixture. Mixture was filtered and washed with acetic acid (40 mL). Filtrate was d istil lated and to the residue cone. HCI (20 mL), water (10 mL) and toluene (30mL) were charged. Mixture was heated to 65°C and stirred for 2 hours. The mixture was cooled to 5°C and the solid precipitant was filtered, washed with toluene (20 mL) and dried under vacuum, to give 12 gr solid product of compound (VI), 85% yield.
Example 11: Preparation of (3-Chloro-5-(trifluoromethyl)pyridin-2-yl)methanamine Hydrochloride (compound VI) from Methyl-2-(3-chloro-5-(trifluoromethyl)pyridine-2-yl)-(hydroxylimine)acetate (compound I) via methyl 2-amino-2-(3-chloro-5-trifluoromehtyl)pyridine-2-yl)acetate (compound V)
To a IL autoclave reactor, Methyl-2-(3-chloro-5-(trifluoromethyl) pyridi ne-2-yl)- (hydroxylimine)acetate (70 gr), acetic acid (200 mL) were charged and stirred for 10 minutes at 10°C. Zinc dust (40.8 gr) was added at 10°C and mixture was stirred for 2 hours. The reaction progress was monitored by HPLC and ended when compound (I) was less than 0.5% in the
reaction mixture. Mixture was filtered and washed with acetic acid (50 mL). Filtrate was distillated and to the residue, cone. HCI (20 mL), was charged. Mixture was heated to 100°C and stirred for 5 hours. The reaction progress was monitored by HPLC and ended when compound (V) was less than 0.5% in the reaction mixture. Water was distilled out from the solution and the oily residue was dissolved in toluene (150 mL). The mixture was cooled to 5°C and the solid precipitant was filtered. The solid residue was washed with toluene (50 mL) and dried under vacuum, to give 46.5 gr solid product of compound (VI), 83% yield.
Example 12: Preparation of (3-Chloro-5-(trifluoromethyl)pyridin-2-yl)methanamine Hydrochloride (compound VI) from 2,3-Dichloro-5-(trifluoro methyl)pyridine (compound IV) & Diethylacetamidomalonate (compound X) via Diethyl-2-acetamido-2-(3-chloro-5- (trifluoromethyl)pyridine-2-yl)malonate (compound XI)
To a 2L reactor, 2,3-dichloro-5-(trifluoromethyl)pyridine (100 gr), diethyl-2-acetamidomalonate (106.7 gr), potassium carbonate (130.6 gr), tetra-n-butylammonium bromide(14.8 gr) and dimethyl sulfoxide (400 mL) were charged and the resulting mixture was heated to 80°C for 13 hours. The reaction progress was monitored by HPLC and ended when compound (IV) was less than 2.0% in the reaction mixture. Mixture was cooled to 25°C and water (1000 mL) and toluene (500 mL) were charged. After that, the mixture was stirred for 20 minutes, and organic layer was separated. Aqueous layer was washed with toluene (200 mL) and organic phases were combined. Organic phases were washed with water (200 mL) and separated. Toluene was distillated to give oily residue. Cone. HCI (307 gr) was charged, and the mixture was heated to 105°C for 15 hours. The reaction progress was monitored by HPLC and ended when compound (XI) was less than 0.5% in the reaction mixture. The mixture was cooled to 65°C and distillated to lower volume. The mixture was further cooled to 25°C and toluene (200 mL) was charged. Mixture was heated to 70°C for 1 hour. Mixture was cooled to 5°C for 1 hour and solid was filtered, washed with toluene (100 mL) and vacuum dried to give 73 gr solid product of compound (VI), 63% yield.
Example 13: Preparation of 2,6-dichloro-N-((3-chloro-5-(trifluoromethyl)pyridin-2- yl)methyl)benzamide (compound VIII) by 2,6-dichlorobenzoyl chloride (compound VII) & (3-chloro- 5(trifluoromethyl)pyridin-2-yl)methanamine (compound VI)
To a IL reactor, water (400 mL) and sodium hydroxide (34.7 gr) were charged, the resulting mixture was cooled to 15°C and 3-chloro-5-(trifluoromethyl)pyridine-2-yl)methanamine hydrogen chloride salt (1033.95 gr) was charged. Then, 2,6-dichlorobenzoyl chloride (91.31 gr) was charged dropwise, maintaining the temperature between 15°C. Toluene (10 mL) was used to wash any solid remains to the reactor. Mixture was allowed to stir at 25°C for 2 hours. The reaction progress was monitored by HPLC and ended when compound (VI) was less than 0.5% in the reaction mixture. Solid was filtered, washed with water (200 mL) and dried under vacuum. Solid was dissolved in toluene (200 mL and washed with water (200 mL) at 25°C. Mixture was heated to 90°C for 30 minutes and cooled to 5°C for 1 hour. Solid was filtered, washed with toluene (50 mL) at 5°C and dried under vacuum to give 143.6 gr solid product of compound (VIII), 92% yield.
Claims
CLAIMS:
Z is, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; p is 0-4
2. A compound of formula (la) g a compound of formula (I)
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z is, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; p is 0-4 comprising reaction of a compound of formula (II) or its salts thereof
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z is, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; p is 0-4 with a nitrite salt selected from the group comprising sodium nitrite, potassium nitrite, ammonium nitrite and the mixture thereof, in the presence of solvent, optionally in the presence of an acid, and optionally in the presence of phase transfer catalyst.
4. A process according to claim 3 wherein the nitrite salt is sodium nitrite.
5. A process according to claim 3 wherein the solvent is selected from the group comprising aliphatic cyclic and acyclic hydrocarbons, halogenated aliphatic cyclic and acyclic hydrocarbons, aromatic hydrocarbons, halogenated aromatic hydrocarbons, ethers, aliphatic and aromatic esters, nitriles, ketones, C1-C4 alcohols, n-alkyls pyrrolidones, dimethylformamide, dimethylacetamide, dimethyl sulfoxide, water, and the mixture thereof.
6. A process according to claim 3 performed in the presence of an acid selected from the group comprising acetic acid, formic acid, chloroacetic acid, dichloroacetic acid, trifluoroacetic acid, carboxylic acids, sulfuric acid, phosphoric acid, para-toluene sulfonic acid, hydrochloric acid, and the mixture thereof.
7. The process according to claim 3 performed in the presence of phase transfer catalyst selected from quaternary ammonium salts, phosphonium salts, crown ethers, polyether's and the mixtures thereof. Wherein the phase transfer catalyst selected from a group comprising benzyltriethylammonium chloride, methyltricaprylammonium chloride, methyltributylammonium chloride, and methyltrioctylammonium chloride, tetra-n- butylammoniumchloride, tetra-n-butylammonium bromide, tetra-n-butylammonium iodide, tetra-n-butylammonium fluoride, crown ethers, polyethylene glycols, polypropylene glycols, and the mixture thereof.
8. A process of preparing a compound of formula (II) or its salts thereof,
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z is, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; p is 0-4 comprising reaction of compound of formula (III) or its salts thereof
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z1, Z2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3. p is 0-4 with an acid selected form the group consisting of trifluoroacetic acid, hydrochloric acid, hydrobromic acid, sulfuric acid, methane sulfonic acid, para-toluene sulfonic acid, phosphoric acid. And/or a with alkaline metal halides selected from a group consisting of sodium chloride, potassium chloride, lithium chloride, sodium bromide, potassium bromide, lithium bromide.
9. A process of preparing a compound of formula (III), or its salts thereof
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z1, Z2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; p is 0-4 comprising reaction of compound of formula (IV)
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 with compound of formula A
Z1, Z2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; in the presence of a base and a phase transfer catalyst, optionally in the presence of solvent.
10. The process according to claim 9, wherein a base is selected from the group comprising of triethylamine, diisopropylethylamine, pyridine, 4-dimethylaminopyridine, potassium carbonate, potassium bicarbonate, sodium carbonate, sodium bicarbonate, sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium C1-C4 alkoxide, potassium C1-C4 alkoxide, potassium tert- butoxide, sodium hydride, potassium hydride, butyl lithium, lithium diisopropyl amine, aniline, p-chloroaniline and the mixtures thereof.
11. The process according to claim 9 performed in the presence of phase transfer catalyst selected from quaternary ammonium salts, phosphonium salts, crown ethers, polyether's and the mixtures thereof. Wherein the phase transfer catalyst selected from a group comprising benzyltriethylammonium chloride, methyltricaprylammonium chloride, methyltributylammonium chloride, and methyltrioctylammonium chloride, tetra-n- butylammoniumchloride, tetra-n-butylammonium bromide, tetra-n-butylammonium iodide, tetra-n-butylammonium fluoride, crown ethers, polyethylene glycols, polypropylene glycols, and the mixture thereof.
12. A process of preparing a compound of formula (II) or its salts thereof,
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z is, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; p is 0-4 comprising heating of compound of formula (III) or its salts thereof
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z1, Z2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; p is 0-4 at 60-180°C under high pressure of 1-32 bars.
13. A process for preparing a compound of formula (V) or its salts thereof,
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z is, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO R; wherein R is -CH3, -C6H5-CH3; p is 0-4 comprising reaction of compound of formula (I),
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z is, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO R; wherein R is -CH3, -C6H5-CH3; p is 0-4 in the presence of metal catalyst, optionally in the presence of hydrogen, optionally in the presence of carboxylic acid.
14. The process according to claim 13, wherein metal catalyst is selected form the group comprising zinc, iridium, nickel, palladium, platinum, rhodium, or ruthenium, cobalt, tin, iron, Raney Ni, or the corresponding salts selected form the group of chlorides, bromide, iodide, nitrates, and the mixture thereof.
15. The process according to claim 13, performed in the presence of C1-C4 carboxylic acid selected form the group comprising acetic acid, chloroacetic acid, dichloroacetic acid,
trichloroacetic acid, trifluoracetic acid, propionic acid, butyric acid, lactic acid, formic acid, citric acid, oxalic acid, uric acid, malic acid, tartaric acid, and a mixture thereof.
16. A process of preparing a compound of formula (VI) or its salts thereof,
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 comprising a) preparing a compound of formula (V) according to any of claim of claims 13-15 and b) further reaction of resulting a compound of formula (V) with an acid, optionally in the presence of organic solvent.
17. The process according to claim 16 wherein an acid is selected from the group comprising of trifluoroacetic acid, hydrochloric acid, hydrobromic acid, sulfuric acid, methane sulfonic acid, para-toluene sulfonic acid, phosphoric acid, and the mixture thereof.
18. The process according to claim 16 performed in the presence of organic solvent selected from water, halogenated aliphatic cyclic and acyclic hydrocarbons, aromatic hydrocarbons, halogenated aromatic hydrocarbons, dichloromethane, methanol, ethanol, isopropanol, tertbutanol, dimethylformamide, 1,4-dioxane, ethyl acetate, acetonitrile, tetrahydrofuran, acetic acid, toluene, benzene, hexane, cyclohexane, dimethyl sulfoxide, pyridine, diethyl ether, chloroform, 1,2-dichloroethane, 1-chlorobenzene, 1,2-dichlorobenzene, 1,3,5-trichlorobenzene, acetone, isopropyl acetate, anisole, A/-methyl-2-pyrrolidone, 4-methylmorpholine, nitromethane and the mixtures thereof.
X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Y is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4
comprising reaction of compound of formula (VI) prepared according to claim 16 with a compound of formula (VII)
wherein q is an integer equal to 1, 2, 3 or 4,
Y is halogen and
L is a leaving group selected from C1-C6 alkoxy, OH, halogens, hydrogen, OSfO^R; wherein R is - CH3, -C6H5-CH3; q is 0-5 in the presence of organic solvent, optionally in the presence of base.
20. The process according to claim 19 wherein a base is selected from the group comprising of alkali and alkaline earth metal hydroxides, alkoxides, carbonates and bicarbonates and organic primary, secondary and tertiary amines, such as triethylamine, diisopropylethylamine, pyridine, potassium hydroxide, potassium carbonate, potassium bicarbonate, sodium carbonate, sodium bicarbonate, sodium hydroxide, aniline, p-chloroaniline and the mixture thereof.
21. The process according to claim 19 performed in the presence of organic solvent selected from the group comprising aliphatic cyclic and acyclic hydrocarbons, halogenated aliphatic cyclic and acyclic hydrocarbons, aromatic hydrocarbons, halogenated aromatic hydrocarbons, ethers, aliphatic and aromatic esters, nitriles, ketones, C1-C4 alcohols, n-alkyls protic and aprotic polar solvents such as, dichloromethane, chloroform, pyridine, water, tetrahydrofuran, dimethylformamide, ethyl acetate, toluene, 1,4-dioxane, diethyl ether, isopropyl acetate, methanol, ethanol, acetonitrile, pyrrolidones, dimethylformamide, dimethylacetamide, dimethyl sulfoxide, water and the mixtures thereof.
X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Y is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4
q is 0-5 using a compound of formula (I)
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z is, optionally halogen substituted C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; p is 0-4.
Z1, Z2 are independently, optionally halogen substituted C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; p is 0-4.
24. A compound of formula (Xia)
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z1, Z2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; p is 0-4 comprising reaction of compound of formula (IX)
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 with a compound of formula (X)
Z1, Z2 are independently, optionally halogen substituted, C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO R; wherein R is -CH3, -C6H5-CH3;
In the presence of organic solvent, in the presence of base and optionally in the presence of phase transfer catalyst.
26. The process according to claim 25 wherein a base is selected from the group comprising of triethylamine, diisopropylethylamine, pyridine, potassium carbonate, potassium bicarbonate, sodium carbonate, sodium bicarbonate, sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium alkoxide, potassium alkoxide, potassium tert-butoxide, sodium hydride, potassium hydride, butyl lithium, lithium diisopropyl amine, aniline, p-chloroaniline and the mixtures thereof.
27. The process according to claim 25 performed in the presence of organic solvent selected from dichloromethane, chloroform, pyridine, water, tetrahydrofuran, dimethylformamide, ethyl acetate, toluene, 1,4-dioxane, diethyl ether, isopropyl acetate, methanol, ethanol, acetonitrile, dimethylacetamide and the mixtures thereof.
28. The process according to claim 25 performed in the presence of phase transfer catalyst selected from the group comprising of quaternary ammonium salts, phosphonium salts, crown ethers polyether's and the mixtures thereof. Wherein the phase transfer catalyst selected from a group comprising benzyltriethylammonium chloride, methyltricaprylammonium chloride, methyltributylammonium chloride, and methyltrioctylammonium chloride, tetra-n- butylammoniumchloride, tetra-n-butylammonium bromide, tetra-n-butylammonium
iodide, tetra-n-butylammonium fluoride, crown ethers, polyethylene glycols and the mixture thereof.
29. A process of preparing a compound of formula (VI) or its salts thereof,
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 comprising preparing a compound of formula (XI) according to claim 25 and b) further reaction of resulting a compound of formula (XI) with an acid, optionally in the presence of organic solvent.
30. The process according to claim 29 wherein an acid is selected from the group comprising of trifluoroacetic acid, hydrochloric acid, hydrobromic acid, sulfuric acid, methane sulfonic acid, para-toluene sulfonic acid, phosphoric acid, and the mixture thereof.
31. The process according to claim 29 performed in the presence of organic solvent selected from the group comprising of water, halogenated aliphatic cyclic and acyclic hydrocarbons, aromatic hydrocarbons, halogenated aromatic hydrocarbons, dichloromethane, methanol, ethanol, propanol, isopropanol, tert-butanol, dimethylformamide, 1,4- dioxane, ethyl acetate, acetonitrile, tetrahydrofuran, acetic acid, toluene, benzene, hexane, cyclohexane, dimethyl sulfoxide, pyridine, diethyl ether, chloroform, 1,2-dichloroethane, 1-chlorbenzen, 1,2-dichlorobenzene, 1,3,5-trichlorobenzene, acetone, isopropyl acetate, anisole, A/-methyl-2-pyrrolidone, 4-methylmorpholine, nitromethane and the mixtures thereof.
X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Y is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 q is 0-5
comprising reaction of compound of formula (VI) prepared according to claim 29 with compound of formula (VII)
wherein q is an integer equal to 1, 2, 3 or 4,
Y is halogen and
L is a leaving group selected from C1-C6 alkoxy, OH, halogens, hydrogen, OSfO^R; wherein R is - CH3, -C6H5-CH3; q is 0-5
In the presence of organic solvent, optionally in the presence of base.
33. The process according to claim 32 wherein a base is selected from the group comprising of triethylamine, diisopropylethylamine, pyridine, potassium hydroxide, potassium carbonate, potassium bicarbonate, sodium carbonate, sodium bicarbonate, sodium hydroxide, aniline, chloroaniline and the mixture thereof.
34. The process according to claim 32 performed in the presence of organic solvent selected from dichloromethane, chloroform, pyridine, water, tetrahydrofuran, dimethylformamide, ethyl acetate, toluene, 1,4-dioxane, diethyl ether, isopropyl acetate, methanol, ethanol, acetonitrile, dimethylacetamide and the mixtures thereof.
X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Y is halogen, C1-C4 alkyl or C1-C4 haloalkyl; p is 0-4 q is 0-5 using the compound of formula (XI)
wherein X is halogen, C1-C4 alkyl or C1-C4 haloalkyl;
Z1, Z2 are independently, optionally halogen substituted C1-C6 alkoxy, aryloxy, C1-C4 alkylaryloxy, benzyloxy; OH, halogen, C1-C6 alkyl amino, OSfO^R; wherein R is -CH3, -C6H5-CH3; p is 0-4.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN202211040040 | 2022-07-12 | ||
IN202211040040 | 2022-07-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024013736A1 true WO2024013736A1 (en) | 2024-01-18 |
Family
ID=87517295
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2023/050715 WO2024013736A1 (en) | 2022-07-12 | 2023-07-10 | Process for preparing substituted benzamides |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2024013736A1 (en) |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999042447A1 (en) | 1998-02-19 | 1999-08-26 | Aventis Cropscience Uk Limited | 2-pyridylmethylamine derivatives useful as fungicides |
WO2002016322A2 (en) | 2000-08-25 | 2002-02-28 | Bayer Cropscience Sa | Process for the preparation of 2-aminoethylpyridines |
WO2004046114A1 (en) | 2002-11-20 | 2004-06-03 | Bayer Cropscience S.A. | Novel process for the preparation of 2-aminomethylpyridine derivative |
WO2004065359A2 (en) | 2002-11-20 | 2004-08-05 | Bayer Cropscience S.A. | Process for the preparation of 2-aminomethylpyridine derivative |
WO2009070485A1 (en) * | 2007-11-29 | 2009-06-04 | Boehringer Ingelheim International Gmbh | DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-α]IMIDAZOLE-3- CARBOXYLIC ACID AMIDES |
WO2017004500A1 (en) * | 2015-07-02 | 2017-01-05 | Genentech, Inc. | Bicyclic lactams and methods of use thereof |
WO2017123860A1 (en) * | 2016-01-13 | 2017-07-20 | Bristol-Myers Squibb Company | Spiroheptane salicylamides and related compounds as inhibitors of rock |
WO2019089664A1 (en) * | 2017-11-01 | 2019-05-09 | Bristol-Myers Squibb Company | Multicyclic compounds as farnesoid x receptor modulators |
EP3652168A1 (en) * | 2017-07-12 | 2020-05-20 | Bristol-Myers Squibb Company | 5-membered and bicyclic heterocyclic amides as inhibitors of rock |
WO2020214734A1 (en) * | 2019-04-16 | 2020-10-22 | Vivace Therapeutics, Inc. | Bicyclic compounds |
WO2020211839A1 (en) * | 2019-04-19 | 2020-10-22 | Dizal (Jiangsu) Pharmaceutical Co., Ltd. | Jak1 selective kinase inhibitor |
WO2021222556A1 (en) * | 2020-04-29 | 2021-11-04 | Relay Therapeutics, Inc. | PI3K-α INHIBITORS AND METHODS OF USE THEREOF |
WO2022087634A1 (en) * | 2020-10-23 | 2022-04-28 | Nimbus Clotho, Inc. | Ctps1 inhibitors and uses thereof |
-
2023
- 2023-07-10 WO PCT/IL2023/050715 patent/WO2024013736A1/en unknown
Patent Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999042447A1 (en) | 1998-02-19 | 1999-08-26 | Aventis Cropscience Uk Limited | 2-pyridylmethylamine derivatives useful as fungicides |
EP1056723A1 (en) | 1998-02-19 | 2000-12-06 | Aventis CropScience UK Limited | 2-pyridylmethylamine derivatives useful as fungicides |
EP1056723B1 (en) * | 1998-02-19 | 2007-11-28 | Bayer CropScience Limited | 2-pyridylmethylamine derivatives useful as fungicides |
WO2002016322A2 (en) | 2000-08-25 | 2002-02-28 | Bayer Cropscience Sa | Process for the preparation of 2-aminoethylpyridines |
WO2004046114A1 (en) | 2002-11-20 | 2004-06-03 | Bayer Cropscience S.A. | Novel process for the preparation of 2-aminomethylpyridine derivative |
WO2004065359A2 (en) | 2002-11-20 | 2004-08-05 | Bayer Cropscience S.A. | Process for the preparation of 2-aminomethylpyridine derivative |
WO2009070485A1 (en) * | 2007-11-29 | 2009-06-04 | Boehringer Ingelheim International Gmbh | DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-α]IMIDAZOLE-3- CARBOXYLIC ACID AMIDES |
WO2017004500A1 (en) * | 2015-07-02 | 2017-01-05 | Genentech, Inc. | Bicyclic lactams and methods of use thereof |
WO2017123860A1 (en) * | 2016-01-13 | 2017-07-20 | Bristol-Myers Squibb Company | Spiroheptane salicylamides and related compounds as inhibitors of rock |
EP3652168A1 (en) * | 2017-07-12 | 2020-05-20 | Bristol-Myers Squibb Company | 5-membered and bicyclic heterocyclic amides as inhibitors of rock |
WO2019089664A1 (en) * | 2017-11-01 | 2019-05-09 | Bristol-Myers Squibb Company | Multicyclic compounds as farnesoid x receptor modulators |
WO2020214734A1 (en) * | 2019-04-16 | 2020-10-22 | Vivace Therapeutics, Inc. | Bicyclic compounds |
WO2020211839A1 (en) * | 2019-04-19 | 2020-10-22 | Dizal (Jiangsu) Pharmaceutical Co., Ltd. | Jak1 selective kinase inhibitor |
WO2021222556A1 (en) * | 2020-04-29 | 2021-11-04 | Relay Therapeutics, Inc. | PI3K-α INHIBITORS AND METHODS OF USE THEREOF |
WO2022087634A1 (en) * | 2020-10-23 | 2022-04-28 | Nimbus Clotho, Inc. | Ctps1 inhibitors and uses thereof |
Non-Patent Citations (6)
Title |
---|
IZDEBSKI, JAN: "New Reagents Suppressing Racemization in Peptide Synthesis by the DCC Method", POLISH JOURNAL OF CHEMISTRY, vol. 53, 1979, pages 1049 - 1057, XP009547354 * |
KIM HA YOUNG ET AL: "Relative Reactivity of a nti - and s yn -Oximino Carbonates and Carbamates of 2-Pyridylacetic Acid Esters", ORGANIC LETTERS, vol. 3, no. 14, 1 July 2001 (2001-07-01), US, pages 2137 - 2140, XP093078761, ISSN: 1523-7060, DOI: 10.1021/ol015737n * |
KOLAR PATRIK ET AL: "Heterocycles from amino acids. A novel synthetic approach for imidazo[1,5-a]pyridines and imidazo[1,5-a]quinolines", JOURNAL OF HETEROCYCLIC CHEMISTRY, WILEY-BLACKWELL PUBLISHING, INC, US, vol. 28, no. 7, 1 November 1991 (1991-11-01), pages 1715 - 1720, XP002606731, ISSN: 0022-152X * |
NIROGI RAMAKRISHNA ET AL: "Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as 5-HT4receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, ELSEVIER, AMSTERDAM, NL, vol. 103, 1 September 2015 (2015-09-01), pages 289 - 301, XP029295243, ISSN: 0223-5234, DOI: 10.1016/J.EJMECH.2015.08.051 * |
PFEIFFER F R ET AL: "The preparation of some pyrido and pyridyl derivatives of phenazine and quinoxaline", THE JOURNAL OF ORGANIC CHEMISTRY, AMERICAN CHEMICAL SOCIETY, vol. 31, no. 10, 1 January 1966 (1966-01-01), pages 3384 - 3390, XP002445913, ISSN: 0022-3263, DOI: 10.1021/JO01348A063 * |
SKERLJ RENATO ET AL: "Design of Substituted Imidazolidinylpiperidinylbenzoic Acids as Chemokine Receptor 5 Antagonists: Potent Inhibitors of R5 HIV-1 Replication", JOURNAL OF MEDICINAL CHEMISTRY, vol. 56, no. 20, 24 October 2013 (2013-10-24), US, pages 8049 - 8065, XP093078804, ISSN: 0022-2623, DOI: 10.1021/jm401101p * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2687510B1 (en) | Method for preparing 2,3-dichloropyridine | |
US7321043B2 (en) | Processes for the preparation of 2-aminomethylpyridines and the 2-cyanopyridines used in their preparation | |
US7777045B2 (en) | Process for the preparation of a 2-ethylaminopyridine derivative | |
US7220863B2 (en) | Process for preparing 2-aminopyridine derivatives | |
WO2024013736A1 (en) | Process for preparing substituted benzamides | |
AU2002213948A1 (en) | Process for the preparation of 2-aminoethylpyridines | |
US6022974A (en) | Process for the production of 2-chloro-5-chloromethyl-pyridine | |
JP2001081065A (en) | Method for producing [bis-(trifluoromethyl)-phenyl]- acetic acid, its alkyl ester and dialkyl bis-(trifluoromethyl)-phenyl]-malonate | |
KR102155759B1 (en) | Method for producing bis(3-aminophenyl)disulfides and 3-aminothiols | |
DK150471B (en) | PROCEDURE FOR THE PREPARATION OF TRIFLUORMETHYLPHENOLS | |
JP4320059B2 (en) | Process for producing 5-aminomethyl-chloropyridines | |
KR100818566B1 (en) | Process for the preparation of 2-aminoethylpyridines | |
CZ259498A3 (en) | Process for preparing amides and esters of heteroarylcarboxylic acids | |
JP3046401B2 (en) | 6- [1- (N-Alkoxyimino) ethyl] salicylic acid derivative and method for producing the same | |
JPH0262854A (en) | Production of substituted phenoxyethylamines | |
JPH0414096B2 (en) | ||
JP3481623B2 (en) | Method for producing hydroxylamine ether and salts thereof and intermediate product therefor | |
JP3387723B2 (en) | Method for producing 2-nitroiminohexahydro-1,3,5-triazines | |
JP4509327B2 (en) | Process for producing N, N-disubstituted-4-aminocrotonic acid ester | |
JP2000327629A (en) | Phenylacetic acid derivative, benzonitrile derivative and production thereof | |
EP1199305A1 (en) | Process for the preparation of 2-aminomethylpyridines | |
US6096894A (en) | Production method of 2-(p-alkylphenyl)pyridine compound | |
JP2000327652A (en) | Phthalonitrile derivative and its production | |
WO2024038436A1 (en) | Process for preparing cyantraniliprole via amino-cyano-benzene derivative | |
WO2021250558A1 (en) | Process for the preparation of fluoxastrobin and intermediates thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23748333 Country of ref document: EP Kind code of ref document: A1 |